id	sid	tid	token	lemma	pos
ctmj-52	1	1	chinese	chinese	ADJ
ctmj-52	1	2	traditional	traditional	ADJ
ctmj-52	1	3	medicine	medicine	NOUN
ctmj-52	1	4	journal	journal	NOUN
ctmj-52	1	5	|	|	ADV
ctmj-52	1	6	2020	2020	NUM
ctmj-52	2	1	|	|	ADV
ctmj-52	2	2	vol	vol	NOUN
ctmj-52	2	3	3	3	NUM
ctmj-52	2	4	|	|	ADV
ctmj-52	2	5	issue	issue	VERB
ctmj-52	2	6	5	5	NUM
ctmj-52	2	7	issn	issn	X
ctmj-52	2	8	:	:	PUNCT
ctmj-52	2	9	2693	2693	NUM
ctmj-52	2	10	6356	6356	NUM
ctmj-52	2	11	2020	2020	NUM
ctmj-52	2	12	|	|	ADV
ctmj-52	2	13	vol	vol	NOUN
ctmj-52	2	14	3	3	NUM
ctmj-52	2	15	|	|	ADV
ctmj-52	2	16	issue	issue	VERB
ctmj-52	2	17	5	5	NUM
ctmj-52	2	18	ctmj	ctmj	NOUN
ctmj-52	2	19	|	|	ADV
ctmj-52	2	20	traditionalmedicinejournals.com	traditionalmedicinejournals.com	X
ctmj-52	2	21	a	a	DET
ctmj-52	2	22	rare	rare	ADJ
ctmj-52	2	23	insulmame	insulmame	ADJ
ctmj-52	2	24	-	-	PUNCT
ctmj-52	2	25	mediated	mediate	VERB
ctmj-52	2	26	pyroptosis	pyroptosis	NOUN
ctmj-52	2	27	cure	cure	NOUN
ctmj-52	2	28	that	that	PRON
ctmj-52	2	29	may	may	AUX
ctmj-52	2	30	be	be	AUX
ctmj-52	2	31	used	use	VERB
ctmj-52	2	32	to	to	PART
ctmj-52	2	33	address	address	VERB
ctmj-52	2	34	acute	acute	ADJ
ctmj-52	2	35	pancreatitis	pancreatitis	PROPN
ctmj-52	2	36	dr.aneela	dr.aneela	ADP
ctmj-52	2	37	1	1	NUM
ctmj-52	2	38	,	,	PUNCT
ctmj-52	2	39	dr.y.sirisha	dr.y.sirisha	PROPN
ctmj-52	2	40	2	2	NUM
ctmj-52	2	41	,	,	PUNCT
ctmj-52	2	42	adithyamathur	adithyamathur	PROPN
ctmj-52	2	43	3	3	NUM
ctmj-52	2	44	,	,	PUNCT
ctmj-52	2	45	ashraful	ashraful	NOUN
ctmj-52	2	46	alom	alom	PROPN
ctmj-52	2	47	4	4	NUM
ctmj-52	2	48	,	,	PUNCT
ctmj-52	2	49	assistant	assistant	NOUN
ctmj-52	2	50	professor	professor	NOUN
ctmj-52	2	51	1,2,3,4	1,2,3,4	NUM
ctmj-52	2	52	,	,	PUNCT
ctmj-52	2	53	department	department	NOUN
ctmj-52	2	54	of	of	ADP
ctmj-52	2	55	pharmacy	pharmacy	NOUN
ctmj-52	2	56	,	,	PUNCT
ctmj-52	2	57	samskruti	samskruti	PROPN
ctmj-52	2	58	college	college	PROPN
ctmj-52	2	59	of	of	ADP
ctmj-52	2	60	pharmacy	pharmacy	NOUN
ctmj-52	2	61	,	,	PUNCT
ctmj-52	2	62	kondapur	kondapur	NOUN
ctmj-52	2	63	(	(	PUNCT
ctmj-52	2	64	v	v	NOUN
ctmj-52	2	65	)	)	PUNCT
ctmj-52	2	66	,	,	PUNCT
ctmj-52	2	67	ghatkesar	ghatkesar	VERB
ctmj-52	2	68	(	(	PUNCT
ctmj-52	2	69	m	m	NOUN
ctmj-52	2	70	)	)	PUNCT
ctmj-52	2	71	medchal	medchal	ADJ
ctmj-52	2	72	dist	dist	NOUN
ctmj-52	2	73	,	,	PUNCT
ctmj-52	2	74	telangana	telangana	PROPN
ctmj-52	2	75	,	,	PUNCT
ctmj-52	2	76	india	india	PROPN
ctmj-52	2	77	.	.	PUNCT
ctmj-52	3	1	abstract	abstract	ADJ
ctmj-52	3	2	this	this	DET
ctmj-52	3	3	study	study	NOUN
ctmj-52	3	4	aims	aim	VERB
ctmj-52	3	5	to	to	PART
ctmj-52	3	6	examine	examine	VERB
ctmj-52	3	7	the	the	DET
ctmj-52	3	8	role	role	NOUN
ctmj-52	3	9	of	of	ADP
ctmj-52	3	10	membrane	membrane	NOUN
ctmj-52	3	11	-	-	PUNCT
ctmj-52	3	12	associated	associate	VERB
ctmj-52	3	13	ring	ring	NOUN
ctmj-52	3	14	-	-	PUNCT
ctmj-52	3	15	ch	ch	NOUN
ctmj-52	3	16	-	-	PUNCT
ctmj-52	3	17	type	type	NOUN
ctmj-52	3	18	finger	finger	NOUN
ctmj-52	3	19	9	9	NUM
ctmj-52	3	20	(	(	PUNCT
ctmj-52	3	21	march9	march9	NOUN
ctmj-52	3	22	)	)	PUNCT
ctmj-52	3	23	in	in	ADP
ctmj-52	3	24	the	the	DET
ctmj-52	3	25	regulation	regulation	NOUN
ctmj-52	3	26	of	of	ADP
ctmj-52	3	27	acute	acute	PROPN
ctmj-52	3	28	pancreatitis	pancreatitis	PROPN
ctmj-52	3	29	(	(	PUNCT
ctmj-52	3	30	ap	ap	PROPN
ctmj-52	3	31	)	)	PUNCT
ctmj-52	3	32	.	.	PUNCT
ctmj-52	4	1	methods	method	NOUN
ctmj-52	4	2	:	:	PUNCT
ctmj-52	4	3	ten	ten	NUM
ctmj-52	4	4	healthy	healthy	ADJ
ctmj-52	4	5	persons	person	NOUN
ctmj-52	4	6	and	and	CCONJ
ctmj-52	4	7	fifteen	fifteen	NUM
ctmj-52	4	8	ap	ap	PROPN
ctmj-52	4	9	patients	patient	NOUN
ctmj-52	4	10	hospitalized	hospitalize	VERB
ctmj-52	4	11	to	to	ADP
ctmj-52	4	12	changzhou	changzhou	PROPN
ctmj-52	4	13	second	second	ADJ
ctmj-52	4	14	people	people	NOUN
ctmj-52	4	15	's	's	PART
ctmj-52	4	16	hospital	hospital	NOUN
ctmj-52	4	17	nanjing	nanjing	PROPN
ctmj-52	4	18	,	,	PUNCT
ctmj-52	4	19	china	china	PROPN
ctmj-52	4	20	,	,	PUNCT
ctmj-52	4	21	took	take	VERB
ctmj-52	4	22	part	part	NOUN
ctmj-52	4	23	in	in	ADP
ctmj-52	4	24	the	the	DET
ctmj-52	4	25	research	research	NOUN
ctmj-52	4	26	.	.	PUNCT
ctmj-52	5	1	we	we	PRON
ctmj-52	5	2	tested	test	VERB
ctmj-52	5	3	the	the	DET
ctmj-52	5	4	individuals	individual	NOUN
ctmj-52	5	5	'	'	PART
ctmj-52	5	6	serum	serum	NOUN
ctmj-52	5	7	samples	sample	NOUN
ctmj-52	5	8	for	for	ADP
ctmj-52	5	9	march9	march9	NOUN
ctmj-52	5	10	expression	expression	NOUN
ctmj-52	5	11	.	.	PUNCT
ctmj-52	6	1	inducing	induce	VERB
ctmj-52	6	2	rat	rat	NOUN
ctmj-52	6	3	pancreatic	pancreatic	ADJ
ctmj-52	6	4	acinar	acinar	NOUN
ctmj-52	6	5	(	(	PUNCT
ctmj-52	6	6	pa	pa	PROPN
ctmj-52	6	7	)	)	PUNCT
ctmj-52	6	8	cells	cell	NOUN
ctmj-52	6	9	with	with	ADP
ctmj-52	6	10	ceruletide	ceruletide	NOUN
ctmj-52	6	11	and	and	CCONJ
ctmj-52	6	12	then	then	ADV
ctmj-52	6	13	transfecting	transfecte	VERB
ctmj-52	6	14	them	they	PRON
ctmj-52	6	15	with	with	ADP
ctmj-52	6	16	a	a	DET
ctmj-52	6	17	march9	march9	NOUN
ctmj-52	6	18	overexpression	overexpression	NOUN
ctmj-52	6	19	vector	vector	NOUN
ctmj-52	6	20	allowed	allow	VERB
ctmj-52	6	21	for	for	ADP
ctmj-52	6	22	the	the	DET
ctmj-52	6	23	establishment	establishment	NOUN
ctmj-52	6	24	of	of	ADP
ctmj-52	6	25	an	an	DET
ctmj-52	6	26	ap	ap	PROPN
ctmj-52	6	27	cell	cell	NOUN
ctmj-52	6	28	model	model	NOUN
ctmj-52	6	29	.	.	PUNCT
ctmj-52	7	1	we	we	PRON
ctmj-52	7	2	found	find	VERB
ctmj-52	7	3	the	the	DET
ctmj-52	7	4	molecular	molecular	ADJ
ctmj-52	7	5	structure	structure	NOUN
ctmj-52	7	6	and	and	CCONJ
ctmj-52	7	7	level	level	NOUN
ctmj-52	7	8	of	of	ADP
ctmj-52	7	9	march9	march9	NOUN
ctmj-52	7	10	,	,	PUNCT
ctmj-52	7	11	which	which	PRON
ctmj-52	7	12	are	be	AUX
ctmj-52	7	13	associated	associate	VERB
ctmj-52	7	14	with	with	ADP
ctmj-52	7	15	pyroptosis	pyroptosis	NOUN
ctmj-52	7	16	and	and	CCONJ
ctmj-52	7	17	inflammatory	inflammatory	ADJ
ctmj-52	7	18	cytokines	cytokine	NOUN
ctmj-52	7	19	.	.	PUNCT
ctmj-52	8	1	caspases	caspase	NOUN
ctmj-52	8	2	1	1	NUM
ctmj-52	8	3	activity	activity	NOUN
ctmj-52	8	4	and	and	CCONJ
ctmj-52	8	5	cell	cell	NOUN
ctmj-52	8	6	survival	survival	NOUN
ctmj-52	8	7	rate	rate	NOUN
ctmj-52	8	8	were	be	AUX
ctmj-52	8	9	measured	measure	VERB
ctmj-52	8	10	.	.	PUNCT
ctmj-52	9	1	the	the	DET
ctmj-52	9	2	results	result	NOUN
ctmj-52	9	3	showed	show	VERB
ctmj-52	9	4	that	that	SCONJ
ctmj-52	9	5	both	both	CCONJ
ctmj-52	9	6	the	the	DET
ctmj-52	9	7	serum	serum	NOUN
ctmj-52	9	8	of	of	ADP
ctmj-52	9	9	ap	ap	PROPN
ctmj-52	9	10	patients	patient	NOUN
ctmj-52	9	11	and	and	CCONJ
ctmj-52	9	12	ceruletide	ceruletide	NOUN
ctmj-52	9	13	-	-	PUNCT
ctmj-52	9	14	induced	induce	VERB
ctmj-52	9	15	pa	pa	PROPN
ctmj-52	9	16	cells	cell	NOUN
ctmj-52	9	17	have	have	VERB
ctmj-52	9	18	low	low	ADJ
ctmj-52	9	19	levels	level	NOUN
ctmj-52	9	20	of	of	ADP
ctmj-52	9	21	march9	march9	NOUN
ctmj-52	9	22	.	.	PUNCT
ctmj-52	10	1	the	the	DET
ctmj-52	10	2	survival	survival	NOUN
ctmj-52	10	3	rate	rate	NOUN
ctmj-52	10	4	of	of	ADP
ctmj-52	10	5	ceruletide	ceruletide	NOUN
ctmj-52	10	6	-	-	PUNCT
ctmj-52	10	7	induced	induce	VERB
ctmj-52	10	8	pa	pa	PROPN
ctmj-52	10	9	cells	cell	NOUN
ctmj-52	10	10	was	be	AUX
ctmj-52	10	11	boosted	boost	VERB
ctmj-52	10	12	and	and	CCONJ
ctmj-52	10	13	the	the	DET
ctmj-52	10	14	levels	level	NOUN
ctmj-52	10	15	of	of	ADP
ctmj-52	10	16	inflammatory	inflammatory	ADJ
ctmj-52	10	17	cytokines	cytokine	NOUN
ctmj-52	10	18	and	and	CCONJ
ctmj-52	10	19	components	component	NOUN
ctmj-52	10	20	associated	associate	VERB
ctmj-52	10	21	with	with	ADP
ctmj-52	10	22	pyroptosis	pyroptosis	NOUN
ctmj-52	10	23	were	be	AUX
ctmj-52	10	24	lowered	lower	VERB
ctmj-52	10	25	when	when	SCONJ
ctmj-52	10	26	march9	march9	NOUN
ctmj-52	10	27	was	be	AUX
ctmj-52	10	28	overexpressed	overexpresse	VERB
ctmj-52	10	29	.	.	PUNCT
ctmj-52	11	1	in	in	ADP
ctmj-52	11	2	ceruletide	ceruletide	NOUN
ctmj-52	11	3	-	-	PUNCT
ctmj-52	11	4	induced	induce	VERB
ctmj-52	11	5	pa	pa	PROPN
ctmj-52	11	6	cells	cell	NOUN
ctmj-52	11	7	,	,	PUNCT
ctmj-52	11	8	caspase	caspase	NOUN
ctmj-52	11	9	1	1	NUM
ctmj-52	11	10	activity	activity	NOUN
ctmj-52	11	11	was	be	AUX
ctmj-52	11	12	shown	show	VERB
ctmj-52	11	13	to	to	PART
ctmj-52	11	14	be	be	AUX
ctmj-52	11	15	decreased	decrease	VERB
ctmj-52	11	16	when	when	SCONJ
ctmj-52	11	17	march9	march9	NOUN
ctmj-52	11	18	was	be	AUX
ctmj-52	11	19	overexpressed	overexpresse	VERB
ctmj-52	11	20	.	.	PUNCT
ctmj-52	12	1	furthermore	furthermore	ADV
ctmj-52	12	2	,	,	PUNCT
ctmj-52	12	3	when	when	SCONJ
ctmj-52	12	4	ceruletide	ceruletide	PROPN
ctmj-52	12	5	was	be	AUX
ctmj-52	12	6	used	use	VERB
ctmj-52	12	7	to	to	PART
ctmj-52	12	8	elevate	elevate	VERB
ctmj-52	12	9	pa	pa	PROPN
ctmj-52	12	10	cell	cell	NOUN
ctmj-52	12	11	levels	level	NOUN
ctmj-52	12	12	of	of	ADP
ctmj-52	12	13	il6	il6	NOUN
ctmj-52	12	14	,	,	PUNCT
ctmj-52	12	15	p	p	NOUN
ctmj-52	12	16	-	-	PUNCT
ctmj-52	12	17	stat3	stat3	NOUN
ctmj-52	12	18	/	/	SYM
ctmj-52	12	19	stat3	stat3	NOUN
ctmj-52	12	20	,	,	PUNCT
ctmj-52	12	21	and	and	CCONJ
ctmj-52	12	22	pjak2	pjak2	NOUN
ctmj-52	12	23	/	/	SYM
ctmj-52	12	24	jak2	jak2	NOUN
ctmj-52	12	25	,	,	PUNCT
ctmj-52	12	26	the	the	DET
ctmj-52	12	27	overexpression	overexpression	NOUN
ctmj-52	12	28	of	of	ADP
ctmj-52	12	29	march9	march9	NOUN
ctmj-52	12	30	exhibited	exhibit	VERB
ctmj-52	12	31	a	a	DET
ctmj-52	12	32	negative	negative	ADJ
ctmj-52	12	33	regulatory	regulatory	ADJ
ctmj-52	12	34	impact	impact	NOUN
ctmj-52	12	35	.	.	PUNCT
ctmj-52	13	1	results	result	NOUN
ctmj-52	13	2	:	:	PUNCT
ctmj-52	13	3	march9	march9	NOUN
ctmj-52	13	4	overexpression	overexpression	NOUN
ctmj-52	13	5	inhibits	inhibit	VERB
ctmj-52	13	6	nlrp3	nlrp3	ADV
ctmj-52	13	7	-	-	PUNCT
ctmj-52	13	8	induced	induce	VERB
ctmj-52	13	9	pyroptosis	pyroptosis	NOUN
ctmj-52	13	10	in	in	ADP
ctmj-52	13	11	pa	pa	PROPN
ctmj-52	13	12	cells	cell	NOUN
ctmj-52	13	13	via	via	ADP
ctmj-52	13	14	controlling	control	VERB
ctmj-52	13	15	the	the	DET
ctmj-52	13	16	il6	il6	PROPN
ctmj-52	13	17	/	/	SYM
ctmj-52	13	18	jak	jak	PROPN
ctmj-52	13	19	/	/	SYM
ctmj-52	13	20	stat3	stat3	NOUN
ctmj-52	13	21	pathway	pathway	NOUN
ctmj-52	13	22	;	;	PUNCT
ctmj-52	13	23	this	this	DET
ctmj-52	13	24	finding	finding	NOUN
ctmj-52	13	25	may	may	AUX
ctmj-52	13	26	have	have	VERB
ctmj-52	13	27	implications	implication	NOUN
ctmj-52	13	28	for	for	ADP
ctmj-52	13	29	the	the	DET
ctmj-52	13	30	treatment	treatment	NOUN
ctmj-52	13	31	of	of	ADP
ctmj-52	13	32	ap	ap	PROPN
ctmj-52	13	33	.	.	PUNCT
ctmj-52	14	1	pyroptosis	pyroptosis	PROPN
ctmj-52	14	2	,	,	PUNCT
ctmj-52	14	3	acute	acute	PROPN
ctmj-52	14	4	pancreatitis	pancreatitis	PROPN
ctmj-52	14	5	,	,	PUNCT
ctmj-52	14	6	ar42j	ar42j	NOUN
ctmj-52	14	7	cells	cell	NOUN
ctmj-52	14	8	,	,	PUNCT
ctmj-52	14	9	ceruletide	ceruletide	NOUN
ctmj-52	14	10	.	.	PUNCT
ctmj-52	15	1	introduction	introduction	NOUN
ctmj-52	15	2	acute	acute	PROPN
ctmj-52	15	3	pancreatitis	pancreatitis	PROPN
ctmj-52	15	4	(	(	PUNCT
ctmj-52	15	5	ap	ap	PROPN
ctmj-52	15	6	)	)	PUNCT
ctmj-52	15	7	is	be	AUX
ctmj-52	15	8	an	an	DET
ctmj-52	15	9	acute	acute	ADJ
ctmj-52	15	10	abdominal	abdominal	ADJ
ctmj-52	15	11	disease	disease	NOUN
ctmj-52	15	12	and	and	CCONJ
ctmj-52	15	13	the	the	DET
ctmj-52	15	14	mortality	mortality	NOUN
ctmj-52	15	15	rate	rate	NOUN
ctmj-52	15	16	can	can	AUX
ctmj-52	15	17	reach	reach	VERB
ctmj-52	15	18	47	47	NUM
ctmj-52	15	19	to	to	PART
ctmj-52	15	20	69	69	NUM
ctmj-52	15	21	%	%	NOUN
ctmj-52	16	1	[	[	X
ctmj-52	16	2	1	1	NUM
ctmj-52	16	3	]	]	PUNCT
ctmj-52	16	4	.	.	PUNCT
ctmj-52	17	1	blood	blood	NOUN
ctmj-52	17	2	amylase	amylase	NOUN
ctmj-52	17	3	and	and	CCONJ
ctmj-52	17	4	lipase	lipase	NOUN
ctmj-52	17	5	are	be	AUX
ctmj-52	17	6	significantly	significantly	ADV
ctmj-52	17	7	increased	increase	VERB
ctmj-52	17	8	in	in	ADP
ctmj-52	17	9	ap	ap	PROPN
ctmj-52	17	10	patients	patient	NOUN
ctmj-52	17	11	,	,	PUNCT
ctmj-52	17	12	which	which	PRON
ctmj-52	17	13	can	can	AUX
ctmj-52	17	14	also	also	ADV
ctmj-52	17	15	be	be	AUX
ctmj-52	17	16	accompanied	accompany	VERB
ctmj-52	17	17	by	by	ADP
ctmj-52	17	18	an	an	DET
ctmj-52	17	19	increase	increase	NOUN
ctmj-52	17	20	in	in	ADP
ctmj-52	17	21	blood	blood	NOUN
ctmj-52	17	22	sugar	sugar	NOUN
ctmj-52	17	23	[	[	X
ctmj-52	17	24	2	2	NUM
ctmj-52	17	25	]	]	PUNCT
ctmj-52	17	26	.	.	PUNCT
ctmj-52	18	1	systemic	systemic	ADJ
ctmj-52	18	2	inflammation	inflammation	NOUN
ctmj-52	18	3	brings	bring	VERB
ctmj-52	18	4	a	a	DET
ctmj-52	18	5	second	second	ADJ
ctmj-52	18	6	strike	strike	NOUN
ctmj-52	18	7	to	to	ADP
ctmj-52	18	8	the	the	DET
ctmj-52	18	9	patients	patient	NOUN
ctmj-52	18	10	by	by	ADP
ctmj-52	18	11	increasing	increase	VERB
ctmj-52	18	12	the	the	DET
ctmj-52	18	13	burden	burden	NOUN
ctmj-52	18	14	on	on	ADP
ctmj-52	18	15	organs	organ	NOUN
ctmj-52	18	16	and	and	CCONJ
ctmj-52	18	17	exacerbating	exacerbate	VERB
ctmj-52	18	18	the	the	DET
ctmj-52	18	19	severity	severity	NOUN
ctmj-52	18	20	of	of	ADP
ctmj-52	18	21	ap	ap	PROPN
ctmj-52	19	1	[	[	X
ctmj-52	19	2	3	3	NUM
ctmj-52	19	3	]	]	PUNCT
ctmj-52	19	4	.	.	PUNCT
ctmj-52	20	1	therefore	therefore	ADV
ctmj-52	20	2	,	,	PUNCT
ctmj-52	20	3	seeking	seek	VERB
ctmj-52	20	4	effective	effective	ADJ
ctmj-52	20	5	treatment	treatment	NOUN
ctmj-52	20	6	for	for	ADP
ctmj-52	20	7	ap	ap	PROPN
ctmj-52	20	8	is	be	AUX
ctmj-52	20	9	currently	currently	ADV
ctmj-52	20	10	a	a	DET
ctmj-52	20	11	hot	hot	ADJ
ctmj-52	20	12	topic	topic	NOUN
ctmj-52	20	13	in	in	ADP
ctmj-52	20	14	research	research	NOUN
ctmj-52	20	15	.	.	PUNCT
ctmj-52	21	1	pyroptosis	pyroptosis	NOUN
ctmj-52	21	2	is	be	AUX
ctmj-52	21	3	a	a	DET
ctmj-52	21	4	form	form	NOUN
ctmj-52	21	5	of	of	ADP
ctmj-52	21	6	cell	cell	NOUN
ctmj-52	21	7	death	death	NOUN
ctmj-52	21	8	involving	involve	VERB
ctmj-52	21	9	members	member	NOUN
ctmj-52	21	10	of	of	ADP
ctmj-52	21	11	the	the	DET
ctmj-52	21	12	caspase	caspase	NOUN
ctmj-52	21	13	family	family	NOUN
ctmj-52	22	1	[	[	X
ctmj-52	22	2	4,5	4,5	NUM
ctmj-52	22	3	]	]	PUNCT
ctmj-52	22	4	.	.	PUNCT
ctmj-52	23	1	the	the	DET
ctmj-52	23	2	release	release	NOUN
ctmj-52	23	3	of	of	ADP
ctmj-52	23	4	pro	pro	ADJ
ctmj-52	23	5	-	-	ADJ
ctmj-52	23	6	inflammatory	inflammatory	ADJ
ctmj-52	23	7	cytokines	cytokine	NOUN
ctmj-52	23	8	induced	induce	VERB
ctmj-52	23	9	by	by	ADP
ctmj-52	23	10	activating	activate	VERB
ctmj-52	23	11	nlrp3	nlrp3	ADJ
ctmj-52	23	12	inflammatome	inflammatome	NOUN
ctmj-52	23	13	is	be	AUX
ctmj-52	23	14	one	one	NUM
ctmj-52	23	15	of	of	ADP
ctmj-52	23	16	the	the	DET
ctmj-52	23	17	causes	cause	NOUN
ctmj-52	23	18	of	of	ADP
ctmj-52	23	19	pyroptosis	pyroptosis	NOUN
ctmj-52	23	20	.	.	PUNCT
ctmj-52	24	1	[	[	X
ctmj-52	24	2	6	6	NUM
ctmj-52	24	3	]	]	PUNCT
ctmj-52	24	4	.	.	PUNCT
ctmj-52	25	1	for	for	ADP
ctmj-52	25	2	instance	instance	NOUN
ctmj-52	25	3	,	,	PUNCT
ctmj-52	25	4	the	the	DET
ctmj-52	25	5	activation	activation	NOUN
ctmj-52	25	6	of	of	ADP
ctmj-52	25	7	receptor	receptor	NOUN
ctmj-52	25	8	-	-	PUNCT
ctmj-52	25	9	associated	associate	VERB
ctmj-52	25	10	factor	factor	NOUN
ctmj-52	25	11	6	6	NUM
ctmj-52	25	12	induces	induce	VERB
ctmj-52	25	13	pyroptosis	pyroptosis	NOUN
ctmj-52	25	14	through	through	ADP
ctmj-52	25	15	the	the	DET
ctmj-52	25	16	caspase	caspase	NOUN
ctmj-52	25	17	1/3	1/3	NUM
ctmj-52	25	18	signaling	signal	VERB
ctmj-52	25	19	pathway	pathway	NOUN
ctmj-52	25	20	,	,	PUNCT
ctmj-52	25	21	thereby	thereby	ADV
ctmj-52	25	22	contributing	contribute	VERB
ctmj-52	25	23	to	to	ADP
ctmj-52	25	24	the	the	DET
ctmj-52	25	25	progression	progression	NOUN
ctmj-52	25	26	of	of	ADP
ctmj-52	25	27	ap	ap	PROPN
ctmj-52	26	1	[	[	X
ctmj-52	26	2	7	7	NUM
ctmj-52	26	3	]	]	PUNCT
ctmj-52	26	4	.	.	PUNCT
ctmj-52	27	1	therefore	therefore	ADV
ctmj-52	27	2	,	,	PUNCT
ctmj-52	27	3	inhibiting	inhibit	VERB
ctmj-52	27	4	the	the	DET
ctmj-52	27	5	occurrence	occurrence	NOUN
ctmj-52	27	6	of	of	ADP
ctmj-52	27	7	pancreatic	pancreatic	ADJ
ctmj-52	27	8	cell	cell	NOUN
ctmj-52	27	9	pyroptosis	pyroptosis	NOUN
ctmj-52	27	10	is	be	AUX
ctmj-52	27	11	one	one	NUM
ctmj-52	27	12	of	of	ADP
ctmj-52	27	13	the	the	DET
ctmj-52	27	14	ways	way	NOUN
ctmj-52	27	15	to	to	PART
ctmj-52	27	16	alleviate	alleviate	VERB
ctmj-52	27	17	ap	ap	PROPN
ctmj-52	27	18	.	.	PUNCT
ctmj-52	27	19	membrane	membrane	PROPN
ctmj-52	27	20	associated	associate	VERB
ctmj-52	27	21	ring	ring	NOUN
ctmj-52	27	22	-	-	PUNCT
ctmj-52	27	23	chtype	chtype	NOUN
ctmj-52	27	24	finger	finger	NOUN
ctmj-52	27	25	(	(	PUNCT
ctmj-52	27	26	march	march	PROPN
ctmj-52	27	27	)	)	PUNCT
ctmj-52	27	28	includes	include	VERB
ctmj-52	27	29	11	11	NUM
ctmj-52	27	30	family	family	NOUN
ctmj-52	27	31	members	member	NOUN
ctmj-52	27	32	,	,	PUNCT
ctmj-52	27	33	from	from	ADP
ctmj-52	27	34	march1	march1	PROPN
ctmj-52	27	35	to	to	PART
ctmj-52	27	36	march11	march11	VERB
ctmj-52	27	37	and	and	CCONJ
ctmj-52	27	38	they	they	PRON
ctmj-52	27	39	play	play	VERB
ctmj-52	27	40	a	a	DET
ctmj-52	27	41	role	role	NOUN
ctmj-52	27	42	in	in	ADP
ctmj-52	27	43	immune	immune	ADJ
ctmj-52	27	44	regulation	regulation	NOUN
ctmj-52	27	45	,	,	PUNCT
ctmj-52	27	46	cell	cell	NOUN
ctmj-52	27	47	polarity	polarity	NOUN
ctmj-52	27	48	,	,	PUNCT
ctmj-52	27	49	and	and	CCONJ
ctmj-52	27	50	toll	toll	NOUN
ctmj-52	27	51	like	like	ADP
ctmj-52	27	52	receptor	receptor	NOUN
ctmj-52	27	53	signal	signal	NOUN
ctmj-52	27	54	transduction	transduction	NOUN
ctmj-52	27	55	[	[	X
ctmj-52	27	56	8	8	NUM
ctmj-52	27	57	]	]	PUNCT
ctmj-52	27	58	.	.	PUNCT
ctmj-52	28	1	march9	march9	PROPN
ctmj-52	28	2	,	,	PUNCT
ctmj-52	28	3	a	a	DET
ctmj-52	28	4	member	member	NOUN
ctmj-52	28	5	of	of	ADP
ctmj-52	28	6	the	the	DET
ctmj-52	28	7	march	march	NOUN
ctmj-52	28	8	protein	protein	NOUN
ctmj-52	28	9	family	family	NOUN
ctmj-52	28	10	,	,	PUNCT
ctmj-52	28	11	may	may	AUX
ctmj-52	28	12	be	be	AUX
ctmj-52	28	13	related	relate	VERB
ctmj-52	28	14	to	to	ADP
ctmj-52	28	15	cellular	cellular	ADJ
ctmj-52	28	16	immune	immune	ADJ
ctmj-52	28	17	regulation	regulation	NOUN
ctmj-52	28	18	[	[	X
ctmj-52	28	19	9	9	NUM
ctmj-52	28	20	]	]	PUNCT
ctmj-52	28	21	.	.	PUNCT
ctmj-52	29	1	in	in	ADP
ctmj-52	29	2	addition	addition	NOUN
ctmj-52	29	3	,	,	PUNCT
ctmj-52	29	4	it	it	PRON
ctmj-52	29	5	was	be	AUX
ctmj-52	29	6	recently	recently	ADV
ctmj-52	29	7	shown	show	VERB
ctmj-52	29	8	that	that	SCONJ
ctmj-52	29	9	march9	march9	NOUN
ctmj-52	29	10	regulates	regulate	VERB
ctmj-52	29	11	the	the	DET
ctmj-52	29	12	pancreatic	pancreatic	ADJ
ctmj-52	29	13	cells	cell	NOUN
ctmj-52	29	14	pyroptosis	pyroptosis	NOUN
ctmj-52	29	15	induced	induce	VERB
ctmj-52	29	16	by	by	ADP
ctmj-52	29	17	nlrp3	nlrp3	ADJ
ctmj-52	29	18	inflammasome	inflammasome	NOUN
ctmj-52	29	19	in	in	ADP
ctmj-52	29	20	ap	ap	PROPN
ctmj-52	30	1	[	[	X
ctmj-52	30	2	10	10	NUM
ctmj-52	30	3	]	]	PUNCT
ctmj-52	30	4	.	.	PUNCT
ctmj-52	31	1	this	this	PRON
ctmj-52	31	2	indicates	indicate	VERB
ctmj-52	31	3	that	that	SCONJ
ctmj-52	31	4	march9	march9	NOUN
ctmj-52	31	5	participates	participate	VERB
ctmj-52	31	6	in	in	ADP
ctmj-52	31	7	the	the	DET
ctmj-52	31	8	regulation	regulation	NOUN
ctmj-52	31	9	of	of	ADP
ctmj-52	31	10	ap	ap	PROPN
ctmj-52	31	11	chinese	chinese	PROPN
ctmj-52	31	12	traditional	traditional	ADJ
ctmj-52	31	13	medicine	medicine	NOUN
ctmj-52	31	14	journal	journal	NOUN
ctmj-52	31	15	|	|	ADV
ctmj-52	31	16	2020	2020	NUM
ctmj-52	31	17	|	|	ADV
ctmj-52	31	18	vol	vol	NOUN
ctmj-52	31	19	3	3	NUM
ctmj-52	32	1	|	|	ADV
ctmj-52	32	2	issue	issue	VERB
ctmj-52	32	3	5	5	NUM
ctmj-52	32	4	issn	issn	X
ctmj-52	32	5	:	:	PUNCT
ctmj-52	32	6	2693	2693	NUM
ctmj-52	32	7	6356	6356	NUM
ctmj-52	32	8	2020	2020	NUM
ctmj-52	32	9	|	|	ADV
ctmj-52	32	10	vol	vol	NOUN
ctmj-52	32	11	3	3	NUM
ctmj-52	33	1	|	|	ADV
ctmj-52	33	2	issue	issue	VERB
ctmj-52	33	3	5	5	NUM
ctmj-52	33	4	ctmj	ctmj	NOUN
ctmj-52	33	5	|	|	ADV
ctmj-52	33	6	traditionalmedicinejournals.com	traditionalmedicinejournals.com	X
ctmj-52	33	7	occurrence	occurrence	NOUN
ctmj-52	33	8	.	.	PUNCT
ctmj-52	34	1	the	the	DET
ctmj-52	34	2	study	study	NOUN
ctmj-52	34	3	of	of	ADP
ctmj-52	34	4	march9	march9	NOUN
ctmj-52	34	5	in	in	ADP
ctmj-52	34	6	ap	ap	PROPN
ctmj-52	34	7	is	be	AUX
ctmj-52	34	8	still	still	ADV
ctmj-52	34	9	however	however	ADV
ctmj-52	34	10	immature	immature	ADJ
ctmj-52	34	11	.	.	PUNCT
ctmj-52	35	1	the	the	DET
ctmj-52	35	2	potential	potential	ADJ
ctmj-52	35	3	function	function	NOUN
ctmj-52	35	4	and	and	CCONJ
ctmj-52	35	5	possible	possible	ADJ
ctmj-52	35	6	mechanisms	mechanism	NOUN
ctmj-52	35	7	of	of	ADP
ctmj-52	35	8	march9	march9	NOUN
ctmj-52	35	9	in	in	ADP
ctmj-52	35	10	ap	ap	PROPN
ctmj-52	35	11	was	be	AUX
ctmj-52	35	12	discussed	discuss	VERB
ctmj-52	35	13	in	in	ADP
ctmj-52	35	14	the	the	DET
ctmj-52	35	15	current	current	ADJ
ctmj-52	35	16	study	study	NOUN
ctmj-52	35	17	,	,	PUNCT
ctmj-52	35	18	with	with	ADP
ctmj-52	35	19	the	the	DET
ctmj-52	35	20	intent	intent	NOUN
ctmj-52	35	21	being	be	AUX
ctmj-52	35	22	to	to	PART
ctmj-52	35	23	provide	provide	VERB
ctmj-52	35	24	new	new	ADJ
ctmj-52	35	25	ideas	idea	NOUN
ctmj-52	35	26	for	for	ADP
ctmj-52	35	27	the	the	DET
ctmj-52	35	28	treatment	treatment	NOUN
ctmj-52	35	29	of	of	ADP
ctmj-52	35	30	ap	ap	PROPN
ctmj-52	35	31	.	.	PUNCT
ctmj-52	36	1	methods	method	NOUN
ctmj-52	36	2	clinical	clinical	ADJ
ctmj-52	36	3	samples	sample	NOUN
ctmj-52	36	4	venous	venous	ADJ
ctmj-52	36	5	blood	blood	NOUN
ctmj-52	36	6	(	(	PUNCT
ctmj-52	36	7	10	10	NUM
ctmj-52	36	8	ml	ml	NOUN
ctmj-52	36	9	)	)	PUNCT
ctmj-52	36	10	were	be	AUX
ctmj-52	36	11	collected	collect	VERB
ctmj-52	36	12	from	from	ADP
ctmj-52	36	13	patients	patient	NOUN
ctmj-52	36	14	with	with	ADP
ctmj-52	36	15	ap	ap	PROPN
ctmj-52	36	16	admitted	admit	VERB
ctmj-52	36	17	in	in	ADP
ctmj-52	36	18	changzhou	changzhou	PROPN
ctmj-52	36	19	second	second	ADJ
ctmj-52	36	20	people	people	NOUN
ctmj-52	36	21	's	's	PART
ctmj-52	36	22	hospital	hospital	NOUN
ctmj-52	36	23	nanjing	nanjing	PROPN
ctmj-52	36	24	,	,	PUNCT
ctmj-52	36	25	china	china	PROPN
ctmj-52	36	26	(	(	PUNCT
ctmj-52	36	27	ap	ap	PROPN
ctmj-52	36	28	group	group	PROPN
ctmj-52	36	29	,	,	PUNCT
ctmj-52	36	30	n	n	PROPN
ctmj-52	36	31	=	=	SYM
ctmj-52	36	32	15	15	NUM
ctmj-52	36	33	,	,	PUNCT
ctmj-52	36	34	6	6	NUM
ctmj-52	36	35	females	female	NOUN
ctmj-52	36	36	and	and	CCONJ
ctmj-52	36	37	9	9	NUM
ctmj-52	36	38	males	male	NOUN
ctmj-52	36	39	)	)	PUNCT
ctmj-52	36	40	and	and	CCONJ
ctmj-52	36	41	from	from	ADP
ctmj-52	36	42	15	15	NUM
ctmj-52	36	43	healthy	healthy	ADJ
ctmj-52	36	44	individuals	individual	NOUN
ctmj-52	36	45	(	(	PUNCT
ctmj-52	36	46	normal	normal	ADJ
ctmj-52	36	47	group	group	NOUN
ctmj-52	36	48	,	,	PUNCT
ctmj-52	36	49	n	n	NOUN
ctmj-52	36	50	=	=	SYM
ctmj-52	36	51	15	15	NUM
ctmj-52	36	52	,	,	PUNCT
ctmj-52	36	53	8	8	NUM
ctmj-52	36	54	females	female	NOUN
ctmj-52	36	55	and	and	CCONJ
ctmj-52	36	56	7	7	NUM
ctmj-52	36	57	males	male	NOUN
ctmj-52	36	58	)	)	PUNCT
ctmj-52	36	59	were	be	AUX
ctmj-52	36	60	collected	collect	VERB
ctmj-52	36	61	.	.	PUNCT
ctmj-52	37	1	healthy	healthy	ADJ
ctmj-52	37	2	individuals	individual	NOUN
ctmj-52	37	3	were	be	AUX
ctmj-52	37	4	those	those	PRON
ctmj-52	37	5	who	who	PRON
ctmj-52	37	6	participate	participate	VERB
ctmj-52	37	7	in	in	ADP
ctmj-52	37	8	physical	physical	ADJ
ctmj-52	37	9	examinations	examination	NOUN
ctmj-52	37	10	in	in	ADP
ctmj-52	37	11	outpatient	outpatient	NOUN
ctmj-52	37	12	clinics	clinic	NOUN
ctmj-52	37	13	.	.	PUNCT
ctmj-52	38	1	ap	ap	PROPN
ctmj-52	38	2	patients	patient	NOUN
ctmj-52	38	3	were	be	AUX
ctmj-52	38	4	hospitalized	hospitalize	VERB
ctmj-52	38	5	and	and	CCONJ
ctmj-52	38	6	did	do	AUX
ctmj-52	38	7	not	not	PART
ctmj-52	38	8	suffer	suffer	VERB
ctmj-52	38	9	from	from	ADP
ctmj-52	38	10	any	any	DET
ctmj-52	38	11	disease	disease	NOUN
ctmj-52	38	12	other	other	ADJ
ctmj-52	38	13	than	than	ADP
ctmj-52	38	14	ap	ap	PROPN
ctmj-52	38	15	.	.	PUNCT
ctmj-52	39	1	serum	serum	PROPN
ctmj-52	39	2	was	be	AUX
ctmj-52	39	3	separated	separate	VERB
ctmj-52	39	4	from	from	ADP
ctmj-52	39	5	blood	blood	NOUN
ctmj-52	39	6	sample	sample	NOUN
ctmj-52	39	7	and	and	CCONJ
ctmj-52	39	8	kept	keep	VERB
ctmj-52	39	9	at	at	ADP
ctmj-52	39	10	80	80	NUM
ctmj-52	39	11	°	°	NOUN
ctmj-52	39	12	c	c	NOUN
ctmj-52	39	13	.	.	PUNCT
ctmj-52	40	1	all	all	DET
ctmj-52	40	2	participants	participant	NOUN
ctmj-52	40	3	signed	sign	VERB
ctmj-52	40	4	informed	informed	ADJ
ctmj-52	40	5	consent	consent	NOUN
ctmj-52	40	6	.	.	PUNCT
ctmj-52	41	1	the	the	DET
ctmj-52	41	2	study	study	NOUN
ctmj-52	41	3	was	be	AUX
ctmj-52	41	4	approved	approve	VERB
ctmj-52	41	5	by	by	ADP
ctmj-52	41	6	the	the	DET
ctmj-52	41	7	ethics	ethic	NOUN
ctmj-52	41	8	committee	committee	PROPN
ctmj-52	41	9	of	of	ADP
ctmj-52	41	10	the	the	DET
ctmj-52	41	11	affiliated	affiliated	ADJ
ctmj-52	41	12	changzhou	changzhou	PROPN
ctmj-52	41	13	no	no	INTJ
ctmj-52	41	14	.	.	NOUN
ctmj-52	41	15	2	2	NUM
ctmj-52	41	16	people	people	NOUN
ctmj-52	41	17	's	's	PART
ctmj-52	41	18	hospital	hospital	NOUN
ctmj-52	41	19	with	with	ADP
ctmj-52	41	20	nanjing	nanjing	PROPN
ctmj-52	41	21	medical	medical	PROPN
ctmj-52	41	22	university	university	PROPN
ctmj-52	41	23	(	(	PUNCT
ctmj-52	41	24	approval	approval	NOUN
ctmj-52	41	25	no	no	INTJ
ctmj-52	41	26	.	.	PUNCT
ctmj-52	42	1	[	[	X
ctmj-52	42	2	2023]ky106	2023]ky106	NUM
ctmj-52	42	3	-	-	SYM
ctmj-52	42	4	01	01	NUM
ctmj-52	42	5	)	)	PUNCT
ctmj-52	43	1	and	and	CCONJ
ctmj-52	43	2	complied	comply	VERB
ctmj-52	43	3	with	with	ADP
ctmj-52	43	4	guidelines	guideline	NOUN
ctmj-52	43	5	of	of	ADP
ctmj-52	43	6	world	world	PROPN
ctmj-52	43	7	medical	medical	PROPN
ctmj-52	43	8	association	association	PROPN
ctmj-52	43	9	declaration	declaration	NOUN
ctmj-52	43	10	of	of	ADP
ctmj-52	43	11	helsinki	helsinki	PROPN
ctmj-52	44	1	[	[	X
ctmj-52	44	2	11	11	NUM
ctmj-52	44	3	]	]	PUNCT
ctmj-52	44	4	.	.	PUNCT
ctmj-52	45	1	the	the	DET
ctmj-52	45	2	amylase	amylase	NOUN
ctmj-52	45	3	and	and	CCONJ
ctmj-52	45	4	lipase	lipase	NOUN
ctmj-52	45	5	levels	level	NOUN
ctmj-52	45	6	in	in	ADP
ctmj-52	45	7	the	the	DET
ctmj-52	45	8	patient	patient	NOUN
ctmj-52	45	9	's	's	PART
ctmj-52	45	10	serum	serum	NOUN
ctmj-52	45	11	were	be	AUX
ctmj-52	45	12	assayed	assayed	ADJ
ctmj-52	45	13	using	use	VERB
ctmj-52	45	14	an	an	DET
ctmj-52	45	15	amylase	amylase	NOUN
ctmj-52	45	16	assessment	assessment	NOUN
ctmj-52	45	17	kit	kit	NOUN
ctmj-52	45	18	and	and	CCONJ
ctmj-52	45	19	a	a	DET
ctmj-52	45	20	lipase	lipase	NOUN
ctmj-52	45	21	assessment	assessment	NOUN
ctmj-52	45	22	kit	kit	NOUN
ctmj-52	45	23	.	.	PUNCT
ctmj-52	46	1	all	all	DET
ctmj-52	46	2	kits	kit	NOUN
ctmj-52	46	3	were	be	AUX
ctmj-52	46	4	purchased	purchase	VERB
ctmj-52	46	5	from	from	ADP
ctmj-52	46	6	nanjing	nanjing	PROPN
ctmj-52	46	7	jiancheng	jiancheng	PROPN
ctmj-52	46	8	bioengineering	bioengineering	PROPN
ctmj-52	46	9	institute	institute	PROPN
ctmj-52	46	10	(	(	PUNCT
ctmj-52	46	11	nanjing	nanjing	PROPN
ctmj-52	46	12	,	,	PUNCT
ctmj-52	46	13	jiangsu	jiangsu	PROPN
ctmj-52	46	14	,	,	PUNCT
ctmj-52	46	15	china	china	PROPN
ctmj-52	46	16	)	)	PUNCT
ctmj-52	46	17	.	.	PUNCT
ctmj-52	47	1	cells	cell	NOUN
ctmj-52	47	2	culture	culture	VERB
ctmj-52	47	3	rat	rat	NOUN
ctmj-52	47	4	pa	pa	PROPN
ctmj-52	47	5	cells	cell	NOUN
ctmj-52	47	6	(	(	PUNCT
ctmj-52	47	7	ar42j	ar42j	NOUN
ctmj-52	47	8	cells	cell	NOUN
ctmj-52	47	9	,	,	PUNCT
ctmj-52	47	10	atcc	atcc	NOUN
ctmj-52	47	11	,	,	PUNCT
ctmj-52	47	12	manassas	manassas	PROPN
ctmj-52	47	13	,	,	PUNCT
ctmj-52	47	14	va	va	PROPN
ctmj-52	47	15	,	,	PUNCT
ctmj-52	47	16	usa	usa	PROPN
ctmj-52	47	17	)	)	PUNCT
ctmj-52	47	18	were	be	AUX
ctmj-52	47	19	cultured	cultured	ADJ
ctmj-52	47	20	in	in	ADP
ctmj-52	47	21	dmem	dmem	VERB
ctmj-52	47	22	medium	medium	NOUN
ctmj-52	47	23	(	(	PUNCT
ctmj-52	47	24	5	5	NUM
ctmj-52	47	25	%	%	NOUN
ctmj-52	47	26	co2	co2	NOUN
ctmj-52	47	27	,	,	PUNCT
ctmj-52	47	28	37	37	NUM
ctmj-52	47	29	°	°	NOUN
ctmj-52	47	30	c	c	NOUN
ctmj-52	47	31	)	)	PUNCT
ctmj-52	47	32	.	.	PUNCT
ctmj-52	48	1	streptomycin	streptomycin	PROPN
ctmj-52	48	2	(	(	PUNCT
ctmj-52	48	3	100	100	NUM
ctmj-52	48	4	μg	μg	NOUN
ctmj-52	48	5	/	/	SYM
ctmj-52	48	6	ml	ml	NOUN
ctmj-52	48	7	)	)	PUNCT
ctmj-52	48	8	,	,	PUNCT
ctmj-52	48	9	fetal	fetal	ADJ
ctmj-52	48	10	bovine	bovine	NOUN
ctmj-52	48	11	serum	serum	NOUN
ctmj-52	48	12	(	(	PUNCT
ctmj-52	48	13	10	10	NUM
ctmj-52	48	14	%	%	NOUN
ctmj-52	48	15	)	)	PUNCT
ctmj-52	48	16	and	and	CCONJ
ctmj-52	48	17	penicillin	penicillin	NOUN
ctmj-52	48	18	(	(	PUNCT
ctmj-52	48	19	100	100	NUM
ctmj-52	48	20	u	u	NOUN
ctmj-52	48	21	/	/	SYM
ctmj-52	48	22	ml	ml	NOUN
ctmj-52	48	23	)	)	PUNCT
ctmj-52	48	24	(	(	PUNCT
ctmj-52	48	25	all	all	DET
ctmj-52	48	26	reagents	reagent	NOUN
ctmj-52	48	27	:	:	PUNCT
ctmj-52	48	28	gibco	gibco	NOUN
ctmj-52	48	29	,	,	PUNCT
ctmj-52	48	30	waltham	waltham	PROPN
ctmj-52	48	31	,	,	PUNCT
ctmj-52	48	32	ma	ma	PROPN
ctmj-52	48	33	,	,	PUNCT
ctmj-52	48	34	usa	usa	PROPN
ctmj-52	48	35	)	)	PUNCT
ctmj-52	48	36	were	be	AUX
ctmj-52	48	37	contained	contain	VERB
ctmj-52	48	38	in	in	ADP
ctmj-52	48	39	the	the	DET
ctmj-52	48	40	culture	culture	NOUN
ctmj-52	48	41	medium	medium	NOUN
ctmj-52	48	42	.	.	PUNCT
ctmj-52	48	43	ar42j	ar42j	PUNCT
ctmj-52	49	1	cells	cell	NOUN
ctmj-52	49	2	were	be	AUX
ctmj-52	49	3	separated	separate	VERB
ctmj-52	49	4	into	into	ADP
ctmj-52	49	5	ceruletide	ceruletide	NOUN
ctmj-52	49	6	,	,	PUNCT
ctmj-52	49	7	control	control	NOUN
ctmj-52	49	8	,	,	PUNCT
ctmj-52	49	9	ceruletide	ceruletide	NOUN
ctmj-52	49	10	+	+	CCONJ
ctmj-52	49	11	nc	nc	PROPN
ctmj-52	49	12	,	,	PUNCT
ctmj-52	49	13	and	and	CCONJ
ctmj-52	49	14	ceruletide	ceruletide	NOUN
ctmj-52	49	15	+	+	CCONJ
ctmj-52	49	16	march9	march9	NOUN
ctmj-52	49	17	groups	group	NOUN
ctmj-52	49	18	.	.	PUNCT
ctmj-52	50	1	to	to	PART
ctmj-52	50	2	establish	establish	VERB
ctmj-52	50	3	an	an	DET
ctmj-52	50	4	ap	ap	PROPN
ctmj-52	50	5	cell	cell	NOUN
ctmj-52	50	6	model	model	NOUN
ctmj-52	50	7	,	,	PUNCT
ctmj-52	50	8	ar42j	ar42j	PUNCT
ctmj-52	50	9	cells	cell	NOUN
ctmj-52	50	10	were	be	AUX
ctmj-52	50	11	cultivated	cultivate	VERB
ctmj-52	50	12	in	in	ADP
ctmj-52	50	13	the	the	DET
ctmj-52	50	14	medium	medium	NOUN
ctmj-52	50	15	complemented	complement	VERB
ctmj-52	50	16	with	with	ADP
ctmj-52	50	17	ceruletide	ceruletide	NOUN
ctmj-52	50	18	(	(	PUNCT
ctmj-52	50	19	100	100	NUM
ctmj-52	50	20	nmol	nmol	NOUN
ctmj-52	50	21	/	/	SYM
ctmj-52	50	22	l	l	PROPN
ctmj-52	50	23	,	,	PUNCT
ctmj-52	50	24	mce	mce	PROPN
ctmj-52	50	25	,	,	PUNCT
ctmj-52	50	26	china	china	PROPN
ctmj-52	50	27	)	)	PUNCT
ctmj-52	50	28	for	for	ADP
ctmj-52	50	29	24	24	NUM
ctmj-52	50	30	h.	h.	PROPN
ctmj-52	50	31	march9	march9	NOUN
ctmj-52	50	32	overexpression	overexpression	NOUN
ctmj-52	50	33	vector	vector	NOUN
ctmj-52	50	34	(	(	PUNCT
ctmj-52	50	35	march9	march9	NOUN
ctmj-52	50	36	)	)	PUNCT
ctmj-52	50	37	and	and	CCONJ
ctmj-52	50	38	the	the	DET
ctmj-52	50	39	negative	negative	ADJ
ctmj-52	50	40	control	control	NOUN
ctmj-52	50	41	(	(	PUNCT
ctmj-52	50	42	nc	nc	PROPN
ctmj-52	50	43	)	)	PUNCT
ctmj-52	50	44	were	be	AUX
ctmj-52	50	45	got	get	VERB
ctmj-52	50	46	from	from	ADP
ctmj-52	50	47	genepharma	genepharma	NOUN
ctmj-52	50	48	(	(	PUNCT
ctmj-52	50	49	shanghai	shanghai	PROPN
ctmj-52	50	50	,	,	PUNCT
ctmj-52	50	51	china	china	PROPN
ctmj-52	50	52	)	)	PUNCT
ctmj-52	50	53	.	.	PUNCT
ctmj-52	51	1	the	the	DET
ctmj-52	51	2	cells	cell	NOUN
ctmj-52	51	3	were	be	AUX
ctmj-52	51	4	harvested	harvest	VERB
ctmj-52	51	5	24	24	NUM
ctmj-52	51	6	h	h	NOUN
ctmj-52	51	7	after	after	ADP
ctmj-52	51	8	transfecting	transfecte	VERB
ctmj-52	51	9	by	by	ADP
ctmj-52	51	10	lipofectamine	lipofectamine	PROPN
ctmj-52	51	11	2000	2000	NUM
ctmj-52	51	12	.	.	PUNCT
ctmj-52	52	1	western	western	ADJ
ctmj-52	52	2	blotting	blotting	NOUN
ctmj-52	52	3	and	and	CCONJ
ctmj-52	52	4	rna	rna	NOUN
ctmj-52	52	5	extraction	extraction	NOUN
ctmj-52	52	6	and	and	CCONJ
ctmj-52	52	7	quantitative	quantitative	ADJ
ctmj-52	52	8	real	real	ADJ
ctmj-52	52	9	time	time	NOUN
ctmj-52	52	10	-	-	PUNCT
ctmj-52	52	11	pcr	pcr	ADJ
ctmj-52	52	12	(	(	PUNCT
ctmj-52	52	13	qrt	qrt	NOUN
ctmj-52	52	14	-	-	PUNCT
ctmj-52	52	15	pcr	pcr	NOUN
ctmj-52	52	16	)	)	PUNCT
ctmj-52	52	17	the	the	DET
ctmj-52	52	18	western	western	ADJ
ctmj-52	52	19	blotting	blotting	NOUN
ctmj-52	52	20	and	and	CCONJ
ctmj-52	52	21	qrt	qrt	ADJ
ctmj-52	52	22	-	-	PUNCT
ctmj-52	52	23	pcr	pcr	NOUN
ctmj-52	52	24	procedures	procedure	NOUN
ctmj-52	52	25	are	be	AUX
ctmj-52	52	26	based	base	VERB
ctmj-52	52	27	on	on	ADP
ctmj-52	52	28	previous	previous	ADJ
ctmj-52	52	29	research	research	NOUN
ctmj-52	52	30	.	.	PUNCT
ctmj-52	53	1	the	the	DET
ctmj-52	53	2	relative	relative	ADJ
ctmj-52	53	3	expressions	expression	NOUN
ctmj-52	53	4	of	of	ADP
ctmj-52	53	5	interleukin-6	interleukin-6	PROPN
ctmj-52	53	6	(	(	PUNCT
ctmj-52	53	7	il-6	il-6	NUM
ctmj-52	53	8	)	)	PUNCT
ctmj-52	53	9	,	,	PUNCT
ctmj-52	53	10	march9	march9	NOUN
ctmj-52	53	11	,	,	PUNCT
ctmj-52	53	12	tumor	tumor	NOUN
ctmj-52	53	13	necrosis	necrosis	NOUN
ctmj-52	53	14	factor	factor	NOUN
ctmj-52	53	15	α	α	PROPN
ctmj-52	53	16	(	(	PUNCT
ctmj-52	53	17	tnf	tnf	PROPN
ctmj-52	53	18	-	-	PUNCT
ctmj-52	53	19	α	α	NOUN
ctmj-52	53	20	)	)	PUNCT
ctmj-52	53	21	and	and	CCONJ
ctmj-52	53	22	il-1β	il-1β	PROPN
ctmj-52	53	23	were	be	AUX
ctmj-52	53	24	measured	measure	VERB
ctmj-52	53	25	,	,	PUNCT
ctmj-52	53	26	and	and	CCONJ
ctmj-52	53	27	their	their	PRON
ctmj-52	53	28	primers	primer	NOUN
ctmj-52	53	29	sequences	sequence	NOUN
ctmj-52	53	30	were	be	AUX
ctmj-52	53	31	listed	list	VERB
ctmj-52	53	32	in	in	ADP
ctmj-52	53	33	table	table	NOUN
ctmj-52	53	34	1	1	NUM
ctmj-52	53	35	.	.	PUNCT
ctmj-52	54	1	the	the	DET
ctmj-52	54	2	primary	primary	ADJ
ctmj-52	54	3	antibodies	antibody	NOUN
ctmj-52	54	4	(	(	PUNCT
ctmj-52	54	5	abcam	abcam	NOUN
ctmj-52	54	6	)	)	PUNCT
ctmj-52	54	7	are	be	AUX
ctmj-52	54	8	as	as	ADV
ctmj-52	54	9	below	below	ADV
ctmj-52	54	10	:	:	PUNCT
ctmj-52	54	11	toll	toll	NOUN
ctmj-52	54	12	-	-	PUNCT
ctmj-52	54	13	like	like	ADJ
ctmj-52	54	14	receptor	receptor	NOUN
ctmj-52	54	15	4	4	NUM
ctmj-52	54	16	(	(	PUNCT
ctmj-52	54	17	tlr4	tlr4	NOUN
ctmj-52	54	18	,	,	PUNCT
ctmj-52	54	19	1:1000	1:1000	NUM
ctmj-52	54	20	)	)	PUNCT
ctmj-52	54	21	,	,	PUNCT
ctmj-52	54	22	march9	march9	NOUN
ctmj-52	54	23	(	(	PUNCT
ctmj-52	54	24	1:1000	1:1000	NUM
ctmj-52	54	25	)	)	PUNCT
ctmj-52	54	26	,	,	PUNCT
ctmj-52	54	27	p65	p65	NOUN
ctmj-52	54	28	(	(	PUNCT
ctmj-52	54	29	1:500	1:500	NUM
ctmj-52	54	30	)	)	PUNCT
ctmj-52	54	31	,	,	PUNCT
ctmj-52	54	32	nlrp3	nlrp3	X
ctmj-52	54	33	(	(	PUNCT
ctmj-52	54	34	1:1000	1:1000	NUM
ctmj-52	54	35	)	)	PUNCT
ctmj-52	54	36	,	,	PUNCT
ctmj-52	54	37	p	p	NOUN
ctmj-52	54	38	-	-	PUNCT
ctmj-52	54	39	p65	p65	NOUN
ctmj-52	54	40	(	(	PUNCT
ctmj-52	54	41	1:500	1:500	NUM
ctmj-52	54	42	)	)	PUNCT
ctmj-52	54	43	,	,	PUNCT
ctmj-52	54	44	il-1β	il-1β	PROPN
ctmj-52	54	45	(	(	PUNCT
ctmj-52	54	46	1:1000	1:1000	NUM
ctmj-52	54	47	)	)	PUNCT
ctmj-52	54	48	,	,	PUNCT
ctmj-52	54	49	gasdermin	gasdermin	NOUN
ctmj-52	54	50	d	d	X
ctmj-52	54	51	(	(	PUNCT
ctmj-52	54	52	1:1000	1:1000	NUM
ctmj-52	54	53	)	)	PUNCT
ctmj-52	54	54	,	,	PUNCT
ctmj-52	54	55	il-6	il-6	NUM
ctmj-52	54	56	(	(	PUNCT
ctmj-52	54	57	1:1000	1:1000	NUM
ctmj-52	54	58	)	)	PUNCT
ctmj-52	54	59	,	,	PUNCT
ctmj-52	54	60	caspase	caspase	NOUN
ctmj-52	54	61	1	1	NUM
ctmj-52	54	62	(	(	PUNCT
ctmj-52	54	63	1:1000	1:1000	NUM
ctmj-52	54	64	)	)	PUNCT
ctmj-52	54	65	,	,	PUNCT
ctmj-52	54	66	il-18	il-18	ADP
ctmj-52	54	67	(	(	PUNCT
ctmj-52	54	68	1:1000	1:1000	NUM
ctmj-52	54	69	)	)	PUNCT
ctmj-52	54	70	,	,	PUNCT
ctmj-52	54	71	janus	janus	PROPN
ctmj-52	54	72	kinase	kinase	PROPN
ctmj-52	54	73	2	2	NUM
ctmj-52	54	74	(	(	PUNCT
ctmj-52	54	75	jak2	jak2	NOUN
ctmj-52	54	76	,	,	PUNCT
ctmj-52	54	77	1:5000	1:5000	NUM
ctmj-52	54	78	)	)	PUNCT
ctmj-52	54	79	,	,	PUNCT
ctmj-52	54	80	signal	signal	NOUN
ctmj-52	54	81	transducer	transducer	NOUN
ctmj-52	54	82	and	and	CCONJ
ctmj-52	54	83	activator	activator	NOUN
ctmj-52	54	84	of	of	ADP
ctmj-52	54	85	transcription	transcription	NOUN
ctmj-52	54	86	3	3	NUM
ctmj-52	54	87	(	(	PUNCT
ctmj-52	54	88	stat3	stat3	NOUN
ctmj-52	54	89	,	,	PUNCT
ctmj-52	54	90	1:1000	1:1000	NUM
ctmj-52	54	91	)	)	PUNCT
ctmj-52	54	92	,	,	PUNCT
ctmj-52	54	93	p	p	PROPN
ctmj-52	54	94	-	-	PUNCT
ctmj-52	54	95	jak2	jak2	NOUN
ctmj-52	54	96	(	(	PUNCT
ctmj-52	54	97	1:500	1:500	NUM
ctmj-52	54	98	)	)	PUNCT
ctmj-52	54	99	,	,	PUNCT
ctmj-52	54	100	pstat3	pstat3	NOUN
ctmj-52	54	101	(	(	PUNCT
ctmj-52	54	102	1:1000	1:1000	NUM
ctmj-52	54	103	)	)	PUNCT
ctmj-52	54	104	and	and	CCONJ
ctmj-52	54	105	gapdh	gapdh	NOUN
ctmj-52	54	106	(	(	PUNCT
ctmj-52	54	107	1:2000	1:2000	NUM
ctmj-52	54	108	)	)	PUNCT
ctmj-52	54	109	.	.	PUNCT
ctmj-52	55	1	immunofluorescence	immunofluorescence	NOUN
ctmj-52	55	2	(	(	PUNCT
ctmj-52	55	3	if	if	SCONJ
ctmj-52	55	4	)	)	PUNCT
ctmj-52	55	5	ar42j	ar42j	PUNCT
ctmj-52	55	6	cells	cell	NOUN
ctmj-52	55	7	were	be	AUX
ctmj-52	55	8	fixed	fix	VERB
ctmj-52	55	9	with	with	ADP
ctmj-52	55	10	paraformaldehyde	paraformaldehyde	NOUN
ctmj-52	55	11	solution	solution	NOUN
ctmj-52	55	12	(	(	PUNCT
ctmj-52	55	13	4	4	NUM
ctmj-52	55	14	%	%	NOUN
ctmj-52	55	15	,	,	PUNCT
ctmj-52	55	16	sigma	sigma	PROPN
ctmj-52	55	17	aldrich	aldrich	PROPN
ctmj-52	55	18	,	,	PUNCT
ctmj-52	55	19	darmstadt	darmstadt	PROPN
ctmj-52	55	20	,	,	PUNCT
ctmj-52	55	21	germany	germany	PROPN
ctmj-52	55	22	)	)	PUNCT
ctmj-52	55	23	and	and	CCONJ
ctmj-52	55	24	then	then	ADV
ctmj-52	55	25	blocked	block	VERB
ctmj-52	55	26	with	with	ADP
ctmj-52	55	27	pbs	pbs	PROPN
ctmj-52	55	28	,	,	PUNCT
ctmj-52	55	29	triton	triton	PROPN
ctmj-52	55	30	(	(	PUNCT
ctmj-52	55	31	0.3	0.3	NUM
ctmj-52	55	32	%	%	NOUN
ctmj-52	55	33	)	)	PUNCT
ctmj-52	55	34	and	and	CCONJ
ctmj-52	55	35	normal	normal	ADJ
ctmj-52	55	36	goat	goat	NOUN
ctmj-52	55	37	serum	serum	NOUN
ctmj-52	55	38	(	(	PUNCT
ctmj-52	55	39	5	5	NUM
ctmj-52	55	40	%	%	NOUN
ctmj-52	55	41	)	)	PUNCT
ctmj-52	55	42	for	for	ADP
ctmj-52	55	43	1	1	NUM
ctmj-52	55	44	hour	hour	NOUN
ctmj-52	55	45	.	.	PUNCT
ctmj-52	56	1	samples	sample	NOUN
ctmj-52	56	2	were	be	AUX
ctmj-52	56	3	cultivated	cultivate	VERB
ctmj-52	56	4	(	(	PUNCT
ctmj-52	56	5	4	4	NUM
ctmj-52	56	6	°	°	NOUN
ctmj-52	56	7	c	c	NOUN
ctmj-52	56	8	)	)	PUNCT
ctmj-52	56	9	overnight	overnight	ADV
ctmj-52	56	10	with	with	ADP
ctmj-52	56	11	an	an	DET
ctmj-52	56	12	anti	anti	ADJ
ctmj-52	56	13	-	-	ADJ
ctmj-52	56	14	march9	march9	ADJ
ctmj-52	56	15	primary	primary	ADJ
ctmj-52	56	16	antibody	antibody	NOUN
ctmj-52	56	17	(	(	PUNCT
ctmj-52	56	18	abcam	abcam	NOUN
ctmj-52	56	19	)	)	PUNCT
ctmj-52	56	20	diluted	dilute	VERB
ctmj-52	56	21	at	at	ADP
ctmj-52	56	22	a	a	DET
ctmj-52	56	23	ratio	ratio	NOUN
ctmj-52	56	24	of	of	ADP
ctmj-52	56	25	1:100	1:100	NUM
ctmj-52	56	26	.	.	PUNCT
ctmj-52	57	1	after	after	ADP
ctmj-52	57	2	that	that	PRON
ctmj-52	57	3	,	,	PUNCT
ctmj-52	57	4	samples	sample	NOUN
ctmj-52	57	5	were	be	AUX
ctmj-52	57	6	cultivated	cultivate	VERB
ctmj-52	57	7	with	with	ADP
ctmj-52	57	8	a	a	DET
ctmj-52	57	9	cy3	cy3	ADV
ctmj-52	57	10	-	-	PUNCT
ctmj-52	57	11	conjugated	conjugate	VERB
ctmj-52	57	12	secondary	secondary	ADJ
ctmj-52	57	13	antibody	antibody	NOUN
ctmj-52	57	14	(	(	PUNCT
ctmj-52	57	15	abcam	abcam	NOUN
ctmj-52	57	16	)	)	PUNCT
ctmj-52	57	17	diluted	dilute	VERB
ctmj-52	57	18	at	at	ADP
ctmj-52	57	19	a	a	DET
ctmj-52	57	20	ratio	ratio	NOUN
ctmj-52	57	21	of	of	ADP
ctmj-52	57	22	1:500	1:500	NUM
ctmj-52	57	23	and	and	CCONJ
ctmj-52	57	24	dapi	dapi	ADV
ctmj-52	57	25	staining	stain	VERB
ctmj-52	57	26	(	(	PUNCT
ctmj-52	57	27	1:1000	1:1000	NUM
ctmj-52	57	28	,	,	PUNCT
ctmj-52	57	29	sigma	sigma	PROPN
ctmj-52	57	30	aldrich	aldrich	PROPN
ctmj-52	57	31	)	)	PUNCT
ctmj-52	57	32	conducted	conduct	VERB
ctmj-52	57	33	for	for	ADP
ctmj-52	57	34	one	one	NUM
ctmj-52	57	35	hour	hour	NOUN
ctmj-52	57	36	at	at	ADP
ctmj-52	57	37	room	room	NOUN
ctmj-52	57	38	temperature	temperature	NOUN
ctmj-52	57	39	.	.	PUNCT
ctmj-52	58	1	the	the	DET
ctmj-52	58	2	images	image	NOUN
ctmj-52	58	3	were	be	AUX
ctmj-52	58	4	collected	collect	VERB
ctmj-52	58	5	by	by	ADP
ctmj-52	58	6	a	a	DET
ctmj-52	58	7	fluorescence	fluorescence	NOUN
ctmj-52	58	8	microscope	microscope	NOUN
ctmj-52	58	9	(	(	PUNCT
ctmj-52	58	10	uy203i	uy203i	NOUN
ctmj-52	58	11	;	;	PUNCT
ctmj-52	58	12	aopu	aopu	NOUN
ctmj-52	58	13	,	,	PUNCT
ctmj-52	58	14	chongqing	chongqing	PROPN
ctmj-52	58	15	,	,	PUNCT
ctmj-52	58	16	sichuan	sichuan	PROPN
ctmj-52	58	17	,	,	PUNCT
ctmj-52	58	18	china	china	PROPN
ctmj-52	58	19	)	)	PUNCT
ctmj-52	58	20	.	.	PUNCT
ctmj-52	59	1	cell	cell	NOUN
ctmj-52	59	2	counting	count	VERB
ctmj-52	59	3	kit‐8	kit‐8	NOUN
ctmj-52	59	4	(	(	PUNCT
ctmj-52	59	5	cck‐8	cck‐8	PROPN
ctmj-52	59	6	)	)	PUNCT
ctmj-52	59	7	assay	assay	VERB
ctmj-52	59	8	the	the	DET
ctmj-52	59	9	cell	cell	NOUN
ctmj-52	59	10	survival	survival	NOUN
ctmj-52	59	11	rate	rate	NOUN
ctmj-52	59	12	was	be	AUX
ctmj-52	59	13	evaluated	evaluate	VERB
ctmj-52	59	14	by	by	ADP
ctmj-52	59	15	cck-8	cck-8	PUNCT
ctmj-52	59	16	method	method	NOUN
ctmj-52	59	17	and	and	CCONJ
ctmj-52	59	18	then	then	ADV
ctmj-52	59	19	planted	plant	VERB
ctmj-52	59	20	in	in	ADP
ctmj-52	59	21	96	96	NUM
ctmj-52	59	22	-	-	PUNCT
ctmj-52	59	23	well	well	NOUN
ctmj-52	59	24	plates	plate	NOUN
ctmj-52	59	25	(	(	PUNCT
ctmj-52	59	26	1	1	NUM
ctmj-52	59	27	×	×	NOUN
ctmj-52	59	28	103	103	NUM
ctmj-52	59	29	cells	cell	NOUN
ctmj-52	59	30	/	/	SYM
ctmj-52	59	31	well	well	INTJ
ctmj-52	59	32	)	)	PUNCT
ctmj-52	59	33	for	for	ADP
ctmj-52	59	34	12	12	NUM
ctmj-52	59	35	h.	h.	NOUN
ctmj-52	59	36	each	each	PRON
ctmj-52	59	37	well	well	INTJ
ctmj-52	59	38	was	be	AUX
ctmj-52	59	39	mixed	mix	VERB
ctmj-52	59	40	with	with	ADP
ctmj-52	59	41	cck‐8	cck‐8	NOUN
ctmj-52	59	42	solution	solution	NOUN
ctmj-52	59	43	(	(	PUNCT
ctmj-52	59	44	10	10	NUM
ctmj-52	59	45	μl	μl	NUM
ctmj-52	59	46	)	)	PUNCT
ctmj-52	59	47	.	.	PUNCT
ctmj-52	60	1	one	one	NUM
ctmj-52	60	2	hour	hour	NOUN
ctmj-52	60	3	later	later	ADV
ctmj-52	60	4	,	,	PUNCT
ctmj-52	60	5	a	a	DET
ctmj-52	60	6	microplate	microplate	NOUN
ctmj-52	60	7	chinese	chinese	PROPN
ctmj-52	60	8	traditional	traditional	ADJ
ctmj-52	60	9	medicine	medicine	NOUN
ctmj-52	60	10	journal	journal	NOUN
ctmj-52	60	11	|	|	ADV
ctmj-52	60	12	2020	2020	NUM
ctmj-52	60	13	|	|	ADV
ctmj-52	60	14	vol	vol	NOUN
ctmj-52	60	15	3	3	NUM
ctmj-52	60	16	|	|	ADV
ctmj-52	60	17	issue	issue	VERB
ctmj-52	60	18	5	5	NUM
ctmj-52	60	19	issn	issn	X
ctmj-52	60	20	:	:	PUNCT
ctmj-52	60	21	2693	2693	NUM
ctmj-52	60	22	6356	6356	NUM
ctmj-52	60	23	2020	2020	NUM
ctmj-52	60	24	|	|	ADV
ctmj-52	60	25	vol	vol	NOUN
ctmj-52	60	26	3	3	NUM
ctmj-52	61	1	|	|	ADV
ctmj-52	61	2	issue	issue	VERB
ctmj-52	61	3	5	5	NUM
ctmj-52	61	4	ctmj	ctmj	NOUN
ctmj-52	61	5	|	|	ADV
ctmj-52	61	6	traditionalmedicinejournals.com	traditionalmedicinejournals.com	X
ctmj-52	61	7	reader	reader	NOUN
ctmj-52	61	8	(	(	PUNCT
ctmj-52	61	9	a51119500c	a51119500c	PROPN
ctmj-52	61	10	;	;	PUNCT
ctmj-52	61	11	thermo	thermo	NOUN
ctmj-52	61	12	fisher	fisher	PROPN
ctmj-52	61	13	)	)	PUNCT
ctmj-52	61	14	was	be	AUX
ctmj-52	61	15	used	use	VERB
ctmj-52	61	16	to	to	PART
ctmj-52	61	17	read	read	VERB
ctmj-52	61	18	the	the	DET
ctmj-52	61	19	absorbance	absorbance	NOUN
ctmj-52	61	20	at	at	ADP
ctmj-52	61	21	450	450	NUM
ctmj-52	61	22	nm	nm	NOUN
ctmj-52	61	23	.	.	PUNCT
ctmj-52	62	1	determination	determination	NOUN
ctmj-52	62	2	of	of	ADP
ctmj-52	62	3	ldh	ldh	ADJ
ctmj-52	62	4	level	level	NOUN
ctmj-52	62	5	lactic	lactic	ADJ
ctmj-52	62	6	dehydrogenase	dehydrogenase	NOUN
ctmj-52	62	7	(	(	PUNCT
ctmj-52	62	8	ldh	ldh	PROPN
ctmj-52	62	9	)	)	PUNCT
ctmj-52	62	10	levels	level	NOUN
ctmj-52	62	11	in	in	ADP
ctmj-52	62	12	the	the	DET
ctmj-52	62	13	ar42j	ar42j	NOUN
ctmj-52	62	14	cells	cell	NOUN
ctmj-52	62	15	were	be	AUX
ctmj-52	62	16	determined	determine	VERB
ctmj-52	62	17	using	use	VERB
ctmj-52	62	18	ldh	ldh	PROPN
ctmj-52	62	19	assay	assay	PROPN
ctmj-52	62	20	kit	kit	NOUN
ctmj-52	62	21	(	(	PUNCT
ctmj-52	62	22	sigma	sigma	PROPN
ctmj-52	62	23	aldrich	aldrich	PROPN
ctmj-52	62	24	)	)	PUNCT
ctmj-52	62	25	.	.	PUNCT
ctmj-52	63	1	flow	flow	VERB
ctmj-52	63	2	cytometry	cytometry	NOUN
ctmj-52	63	3	to	to	PART
ctmj-52	63	4	test	test	VERB
ctmj-52	63	5	pyroptosis	pyroptosis	NOUN
ctmj-52	63	6	in	in	ADP
ctmj-52	63	7	the	the	DET
ctmj-52	63	8	ar42j	ar42j	NOUN
ctmj-52	63	9	cells	cell	NOUN
ctmj-52	63	10	,	,	PUNCT
ctmj-52	63	11	caspase	caspase	NOUN
ctmj-52	63	12	1	1	NUM
ctmj-52	63	13	detection	detection	NOUN
ctmj-52	63	14	kit	kit	NOUN
ctmj-52	63	15	(	(	PUNCT
ctmj-52	63	16	beyotime	beyotime	NOUN
ctmj-52	63	17	,	,	PUNCT
ctmj-52	63	18	shanghai	shanghai	PROPN
ctmj-52	63	19	,	,	PUNCT
ctmj-52	63	20	china	china	PROPN
ctmj-52	63	21	)	)	PUNCT
ctmj-52	63	22	measured	measure	VERB
ctmj-52	63	23	the	the	DET
ctmj-52	63	24	active	active	ADJ
ctmj-52	63	25	levels	level	NOUN
ctmj-52	63	26	of	of	ADP
ctmj-52	63	27	caspase	caspase	PROPN
ctmj-52	63	28	1	1	NUM
ctmj-52	63	29	.	.	PUNCT
ctmj-52	64	1	the	the	DET
ctmj-52	64	2	active	active	ADJ
ctmj-52	64	3	caspase	caspase	NOUN
ctmj-52	64	4	1	1	NUM
ctmj-52	64	5	enzyme	enzyme	NOUN
ctmj-52	64	6	was	be	AUX
ctmj-52	64	7	labeled	label	VERB
ctmj-52	64	8	with	with	ADP
ctmj-52	64	9	fam	fam	NOUN
ctmj-52	64	10	-	-	PUNCT
ctmj-52	64	11	yvad	yvad	NOUN
ctmj-52	64	12	-	-	PUNCT
ctmj-52	64	13	fmk	fmk	PROPN
ctmj-52	64	14	and	and	CCONJ
ctmj-52	64	15	determined	determine	VERB
ctmj-52	64	16	using	use	VERB
ctmj-52	64	17	flow	flow	NOUN
ctmj-52	64	18	cytometry	cytometry	NOUN
ctmj-52	64	19	.	.	PUNCT
ctmj-52	65	1	pyroptosis	pyroptosis	NOUN
ctmj-52	65	2	was	be	AUX
ctmj-52	65	3	defined	define	VERB
ctmj-52	65	4	as	as	ADP
ctmj-52	65	5	being	be	AUX
ctmj-52	65	6	double	double	ADV
ctmj-52	65	7	positive	positive	ADJ
ctmj-52	65	8	for	for	ADP
ctmj-52	65	9	propidium	propidium	NOUN
ctmj-52	65	10	iodide	iodide	NOUN
ctmj-52	65	11	(	(	PUNCT
ctmj-52	65	12	pi	pi	NOUN
ctmj-52	65	13	)	)	PUNCT
ctmj-52	65	14	staining	stain	VERB
ctmj-52	65	15	and	and	CCONJ
ctmj-52	65	16	fam	fam	NOUN
ctmj-52	65	17	-	-	PUNCT
ctmj-52	65	18	yvad	yvad	NOUN
ctmj-52	65	19	-	-	PUNCT
ctmj-52	65	20	fmk	fmk	NOUN
ctmj-52	65	21	.	.	PUNCT
ctmj-52	66	1	statistical	statistical	ADJ
ctmj-52	66	2	analysis	analysis	NOUN
ctmj-52	66	3	the	the	DET
ctmj-52	66	4	data	datum	NOUN
ctmj-52	66	5	was	be	AUX
ctmj-52	66	6	analyzed	analyze	VERB
ctmj-52	66	7	through	through	ADP
ctmj-52	66	8	spss	spss	PROPN
ctmj-52	66	9	20.0	20.0	NUM
ctmj-52	66	10	(	(	PUNCT
ctmj-52	66	11	chicago	chicago	PROPN
ctmj-52	66	12	,	,	PUNCT
ctmj-52	66	13	il	il	PROPN
ctmj-52	66	14	,	,	PUNCT
ctmj-52	66	15	usa	usa	PROPN
ctmj-52	66	16	)	)	PUNCT
ctmj-52	66	17	and	and	CCONJ
ctmj-52	66	18	displayed	display	VERB
ctmj-52	66	19	as	as	ADP
ctmj-52	66	20	sd	sd	NOUN
ctmj-52	66	21	.	.	PUNCT
ctmj-52	67	1	the	the	DET
ctmj-52	67	2	statistical	statistical	ADJ
ctmj-52	67	3	significance	significance	NOUN
ctmj-52	67	4	is	be	AUX
ctmj-52	67	5	assessed	assess	VERB
ctmj-52	67	6	by	by	ADP
ctmj-52	67	7	one	one	NUM
ctmj-52	67	8	-	-	PUNCT
ctmj-52	67	9	way	way	NOUN
ctmj-52	67	10	-	-	PUNCT
ctmj-52	67	11	anova	anova	PROPN
ctmj-52	67	12	followed	follow	VERB
ctmj-52	67	13	by	by	ADP
ctmj-52	67	14	tukey	tukey	PROPN
ctmj-52	67	15	post	post	X
ctmj-52	67	16	hoc	hoc	X
ctmj-52	67	17	test	test	NOUN
ctmj-52	67	18	,	,	PUNCT
ctmj-52	67	19	t	t	NOUN
ctmj-52	67	20	-	-	PUNCT
ctmj-52	67	21	test	test	NOUN
ctmj-52	67	22	.	.	PUNCT
ctmj-52	68	1	p	p	X
ctmj-52	68	2	<	<	X
ctmj-52	68	3	0.05	0.05	NUM
ctmj-52	68	4	was	be	AUX
ctmj-52	68	5	deemed	deem	VERB
ctmj-52	68	6	statistically	statistically	ADV
ctmj-52	68	7	significant	significant	ADJ
ctmj-52	68	8	.	.	PUNCT
ctmj-52	69	1	all	all	DET
ctmj-52	69	2	assays	assay	NOUN
ctmj-52	69	3	were	be	AUX
ctmj-52	69	4	repeated	repeat	VERB
ctmj-52	69	5	as	as	ADP
ctmj-52	69	6	independent	independent	ADJ
ctmj-52	69	7	experiments	experiment	NOUN
ctmj-52	69	8	in	in	ADP
ctmj-52	69	9	at	at	ADV
ctmj-52	69	10	least	least	ADJ
ctmj-52	69	11	triplicate	triplicate	VERB
ctmj-52	69	12	.	.	PUNCT
ctmj-52	70	1	results	result	VERB
ctmj-52	70	2	low	low	ADJ
ctmj-52	70	3	expression	expression	NOUN
ctmj-52	70	4	of	of	ADP
ctmj-52	70	5	serum	serum	NOUN
ctmj-52	70	6	march9	march9	NOUN
ctmj-52	70	7	in	in	ADP
ctmj-52	70	8	ap	ap	PROPN
ctmj-52	70	9	patients	patient	NOUN
ctmj-52	70	10	and	and	CCONJ
ctmj-52	70	11	ap	ap	PROPN
ctmj-52	70	12	cell	cell	NOUN
ctmj-52	70	13	models	model	NOUN
ctmj-52	70	14	serum	serum	VERB
ctmj-52	70	15	samples	sample	NOUN
ctmj-52	70	16	from	from	ADP
ctmj-52	70	17	ap	ap	PROPN
ctmj-52	70	18	patients	patient	NOUN
ctmj-52	70	19	were	be	AUX
ctmj-52	70	20	collected	collect	VERB
ctmj-52	70	21	and	and	CCONJ
ctmj-52	70	22	march9	march9	NOUN
ctmj-52	70	23	expression	expression	NOUN
ctmj-52	70	24	was	be	AUX
ctmj-52	70	25	determined	determine	VERB
ctmj-52	70	26	.	.	PUNCT
ctmj-52	71	1	figure	figure	VERB
ctmj-52	71	2	1	1	NUM
ctmj-52	71	3	a	a	PRON
ctmj-52	71	4	demonstrated	demonstrate	VERB
ctmj-52	71	5	that	that	SCONJ
ctmj-52	71	6	ap	ap	PROPN
ctmj-52	71	7	patients	patient	NOUN
ctmj-52	71	8	showed	show	VERB
ctmj-52	71	9	higher	high	ADJ
ctmj-52	71	10	levels	level	NOUN
ctmj-52	71	11	of	of	ADP
ctmj-52	71	12	serum	serum	NOUN
ctmj-52	71	13	amylase	amylase	NOUN
ctmj-52	71	14	and	and	CCONJ
ctmj-52	71	15	lipase	lipase	NOUN
ctmj-52	71	16	.	.	PUNCT
ctmj-52	72	1	qrt	qrt	PROPN
ctmj-52	72	2	-	-	PUNCT
ctmj-52	72	3	rcr	rcr	ADJ
ctmj-52	72	4	and	and	CCONJ
ctmj-52	72	5	western	western	ADJ
ctmj-52	72	6	blotting	blotting	ADJ
ctmj-52	72	7	results	result	NOUN
ctmj-52	72	8	revealed	reveal	VERB
ctmj-52	72	9	that	that	SCONJ
ctmj-52	72	10	march9	march9	NOUN
ctmj-52	72	11	was	be	AUX
ctmj-52	72	12	lowly	lowly	ADV
ctmj-52	72	13	expressed	express	VERB
ctmj-52	72	14	in	in	ADP
ctmj-52	72	15	serum	serum	NOUN
ctmj-52	72	16	from	from	ADP
ctmj-52	72	17	ap	ap	PROPN
ctmj-52	72	18	patients	patient	NOUN
ctmj-52	72	19	(	(	PUNCT
ctmj-52	72	20	figure	figure	VERB
ctmj-52	72	21	1	1	NUM
ctmj-52	72	22	b	b	NOUN
ctmj-52	72	23	and	and	CCONJ
ctmj-52	72	24	c	c	NOUN
ctmj-52	72	25	)	)	PUNCT
ctmj-52	72	26	.	.	PUNCT
ctmj-52	73	1	moreover	moreover	ADV
ctmj-52	73	2	,	,	PUNCT
ctmj-52	73	3	ap	ap	PROPN
ctmj-52	73	4	cell	cell	NOUN
ctmj-52	73	5	models	model	NOUN
ctmj-52	73	6	were	be	AUX
ctmj-52	73	7	established	establish	VERB
ctmj-52	73	8	using	use	VERB
ctmj-52	73	9	ceruletide	ceruletide	NOUN
ctmj-52	73	10	and	and	CCONJ
ctmj-52	73	11	it	it	PRON
ctmj-52	73	12	was	be	AUX
ctmj-52	73	13	found	find	VERB
ctmj-52	73	14	that	that	SCONJ
ctmj-52	73	15	march9	march9	NOUN
ctmj-52	73	16	expression	expression	NOUN
ctmj-52	73	17	decreased	decrease	VERB
ctmj-52	73	18	in	in	ADP
ctmj-52	73	19	the	the	DET
ctmj-52	73	20	ceruletide	ceruletide	NOUN
ctmj-52	73	21	group	group	NOUN
ctmj-52	73	22	(	(	PUNCT
ctmj-52	73	23	figure	figure	NOUN
ctmj-52	73	24	1	1	NUM
ctmj-52	73	25	d	d	NOUN
ctmj-52	73	26	and	and	CCONJ
ctmj-52	73	27	e	e	NOUN
ctmj-52	73	28	)	)	PUNCT
ctmj-52	73	29	.	.	PUNCT
ctmj-52	74	1	figure	figure	VERB
ctmj-52	74	2	1	1	NUM
ctmj-52	74	3	:	:	PUNCT
ctmj-52	74	4	march9	march9	NOUN
ctmj-52	74	5	expression	expression	NOUN
ctmj-52	74	6	in	in	ADP
ctmj-52	74	7	serum	serum	NOUN
ctmj-52	74	8	of	of	ADP
ctmj-52	74	9	ap	ap	PROPN
ctmj-52	74	10	patients	patient	NOUN
ctmj-52	74	11	and	and	CCONJ
ctmj-52	74	12	ap	ap	NOUN
ctmj-52	74	13	cell	cell	NOUN
ctmj-52	74	14	models	model	NOUN
ctmj-52	74	15	.	.	PUNCT
ctmj-52	75	1	(	(	PUNCT
ctmj-52	75	2	a	a	X
ctmj-52	75	3	)	)	PUNCT
ctmj-52	75	4	levels	level	NOUN
ctmj-52	75	5	of	of	ADP
ctmj-52	75	6	serum	serum	NOUN
ctmj-52	75	7	amylase	amylase	NOUN
ctmj-52	75	8	and	and	CCONJ
ctmj-52	75	9	lipase	lipase	NOUN
ctmj-52	75	10	.	.	PUNCT
ctmj-52	76	1	b	b	X
ctmj-52	76	2	)	)	PUNCT
ctmj-52	76	3	march9	march9	NOUN
ctmj-52	76	4	mrna	mrna	NOUN
ctmj-52	76	5	expression	expression	NOUN
ctmj-52	76	6	.	.	PUNCT
ctmj-52	77	1	(	(	PUNCT
ctmj-52	77	2	c	c	X
ctmj-52	77	3	)	)	PUNCT
ctmj-52	77	4	march9	march9	NOUN
ctmj-52	77	5	protein	protein	NOUN
ctmj-52	77	6	level	level	NOUN
ctmj-52	77	7	.	.	PUNCT
ctmj-52	78	1	(	(	PUNCT
ctmj-52	78	2	d	d	X
ctmj-52	78	3	)	)	PUNCT
ctmj-52	78	4	march9	march9	NOUN
ctmj-52	78	5	mrna	mrna	NOUN
ctmj-52	78	6	expression	expression	NOUN
ctmj-52	78	7	.	.	PUNCT
ctmj-52	79	1	(	(	PUNCT
ctmj-52	79	2	e	e	NOUN
ctmj-52	79	3	)	)	PUNCT
ctmj-52	79	4	march9	march9	NOUN
ctmj-52	79	5	protein	protein	NOUN
ctmj-52	79	6	expression	expression	NOUN
ctmj-52	79	7	.	.	PUNCT
ctmj-52	80	1	*	*	PUNCT
ctmj-52	80	2	*	*	PUNCT
ctmj-52	80	3	*	*	PUNCT
ctmj-52	80	4	p	p	X
ctmj-52	80	5	<	<	X
ctmj-52	80	6	0.05	0.05	NUM
ctmj-52	80	7	,	,	PUNCT
ctmj-52	80	8	vs	vs	ADP
ctmj-52	80	9	normal	normal	ADJ
ctmj-52	80	10	or	or	CCONJ
ctmj-52	80	11	control	control	NOUN
ctmj-52	80	12	overexpression	overexpression	NOUN
ctmj-52	80	13	of	of	ADP
ctmj-52	80	14	march9	march9	NOUN
ctmj-52	80	15	enhanced	enhance	VERB
ctmj-52	80	16	the	the	DET
ctmj-52	80	17	activity	activity	NOUN
ctmj-52	80	18	of	of	ADP
ctmj-52	80	19	ar42j	ar42j	NOUN
ctmj-52	80	20	cells	cell	NOUN
ctmj-52	80	21	induced	induce	VERB
ctmj-52	80	22	by	by	ADP
ctmj-52	80	23	ceruletide	ceruletide	NOUN
ctmj-52	80	24	here	here	ADV
ctmj-52	80	25	,	,	PUNCT
ctmj-52	80	26	ap	ap	PROPN
ctmj-52	80	27	cell	cell	NOUN
ctmj-52	80	28	models	model	NOUN
ctmj-52	80	29	were	be	AUX
ctmj-52	80	30	transfected	transfecte	VERB
ctmj-52	80	31	with	with	ADP
ctmj-52	80	32	march9	march9	NOUN
ctmj-52	80	33	overexpression	overexpression	NOUN
ctmj-52	80	34	vector	vector	NOUN
ctmj-52	80	35	.	.	PUNCT
ctmj-52	81	1	the	the	DET
ctmj-52	81	2	results	result	NOUN
ctmj-52	81	3	showed	show	VERB
ctmj-52	81	4	that	that	SCONJ
ctmj-52	81	5	march9	march9	NOUN
ctmj-52	81	6	level	level	NOUN
ctmj-52	81	7	increased	increase	VERB
ctmj-52	81	8	in	in	ADP
ctmj-52	81	9	ar42j	ar42j	NOUN
ctmj-52	81	10	cells	cell	NOUN
ctmj-52	81	11	induced	induce	VERB
ctmj-52	81	12	by	by	ADP
ctmj-52	81	13	ceruletide	ceruletide	NOUN
ctmj-52	81	14	after	after	ADP
ctmj-52	81	15	transfection	transfection	NOUN
ctmj-52	81	16	with	with	ADP
ctmj-52	81	17	march9	march9	NOUN
ctmj-52	81	18	overexpression	overexpression	NOUN
ctmj-52	81	19	vector	vector	NOUN
ctmj-52	81	20	(	(	PUNCT
ctmj-52	81	21	figure	figure	NOUN
ctmj-52	81	22	2	2	NUM
ctmj-52	81	23	a	a	NOUN
ctmj-52	81	24	)	)	PUNCT
ctmj-52	81	25	.	.	PUNCT
ctmj-52	82	1	in	in	ADP
ctmj-52	82	2	the	the	DET
ctmj-52	82	3	ceruletide	ceruletide	NOUN
ctmj-52	82	4	+	+	CCONJ
ctmj-52	82	5	march9	march9	NOUN
ctmj-52	82	6	group	group	NOUN
ctmj-52	82	7	,	,	PUNCT
ctmj-52	82	8	there	there	PRON
ctmj-52	82	9	was	be	VERB
ctmj-52	82	10	a	a	DET
ctmj-52	82	11	remarkable	remarkable	ADJ
ctmj-52	82	12	increase	increase	NOUN
ctmj-52	82	13	in	in	ADP
ctmj-52	82	14	cell	cell	NOUN
ctmj-52	82	15	survival	survival	NOUN
ctmj-52	82	16	rate	rate	NOUN
ctmj-52	82	17	(	(	PUNCT
ctmj-52	82	18	figure	figure	NOUN
ctmj-52	82	19	2	2	NUM
ctmj-52	82	20	b	b	NOUN
ctmj-52	82	21	)	)	PUNCT
ctmj-52	82	22	,	,	PUNCT
ctmj-52	82	23	and	and	CCONJ
ctmj-52	82	24	a	a	DET
ctmj-52	82	25	rapid	rapid	ADJ
ctmj-52	82	26	reduction	reduction	NOUN
ctmj-52	82	27	in	in	ADP
ctmj-52	82	28	ldh	ldh	PROPN
ctmj-52	82	29	levels	level	NOUN
ctmj-52	82	30	(	(	PUNCT
ctmj-52	82	31	figure	figure	NOUN
ctmj-52	82	32	2	2	NUM
ctmj-52	82	33	c	c	NOUN
ctmj-52	82	34	)	)	PUNCT
ctmj-52	82	35	.	.	PUNCT
ctmj-52	83	1	figure	figure	VERB
ctmj-52	83	2	2	2	NUM
ctmj-52	83	3	:	:	PUNCT
ctmj-52	83	4	the	the	DET
ctmj-52	83	5	role	role	NOUN
ctmj-52	83	6	of	of	ADP
ctmj-52	83	7	march9	march9	NOUN
ctmj-52	83	8	overexpressed	overexpresse	VERB
ctmj-52	83	9	in	in	ADP
ctmj-52	83	10	activity	activity	NOUN
ctmj-52	83	11	of	of	ADP
ctmj-52	83	12	ar42j	ar42j	NOUN
ctmj-52	83	13	cells	cell	NOUN
ctmj-52	83	14	induced	induce	VERB
ctmj-52	83	15	by	by	ADP
ctmj-52	83	16	ceruletide	ceruletide	NOUN
ctmj-52	83	17	.	.	PUNCT
ctmj-52	84	1	ar42j	ar42j	PUNCT
ctmj-52	84	2	cells	cell	NOUN
ctmj-52	84	3	were	be	AUX
ctmj-52	84	4	induced	induce	VERB
ctmj-52	84	5	with	with	ADP
ctmj-52	84	6	ceruletide	ceruletide	NOUN
ctmj-52	84	7	and	and	CCONJ
ctmj-52	84	8	then	then	ADV
ctmj-52	84	9	transfected	transfecte	VERB
ctmj-52	84	10	with	with	ADP
ctmj-52	84	11	march9	march9	NOUN
ctmj-52	84	12	overexpression	overexpression	NOUN
ctmj-52	84	13	vector	vector	NOUN
ctmj-52	84	14	.	.	PUNCT
ctmj-52	85	1	(	(	PUNCT
ctmj-52	85	2	a	a	X
ctmj-52	85	3	)	)	PUNCT
ctmj-52	85	4	immunofluorescence	immunofluorescence	NOUN
ctmj-52	85	5	(	(	PUNCT
ctmj-52	85	6	if	if	SCONJ
ctmj-52	85	7	)	)	PUNCT
ctmj-52	85	8	images	image	NOUN
ctmj-52	85	9	.	.	PUNCT
ctmj-52	86	1	(	(	PUNCT
ctmj-52	86	2	b	b	X
ctmj-52	86	3	)	)	PUNCT
ctmj-52	86	4	cell	cell	NOUN
ctmj-52	86	5	survival	survival	NOUN
ctmj-52	86	6	rate	rate	NOUN
ctmj-52	86	7	.	.	PUNCT
ctmj-52	87	1	(	(	PUNCT
ctmj-52	87	2	c	c	X
ctmj-52	87	3	)	)	PUNCT
ctmj-52	87	4	the	the	DET
ctmj-52	87	5	levels	level	NOUN
ctmj-52	87	6	of	of	ADP
ctmj-52	87	7	ldh	ldh	PROPN
ctmj-52	87	8	.	.	PUNCT
ctmj-52	88	1	*	*	PUNCT
ctmj-52	89	1	*	*	PUNCT
ctmj-52	89	2	*	*	PUNCT
ctmj-52	89	3	p	p	X
ctmj-52	89	4	<	<	X
ctmj-52	89	5	0.05	0.05	NUM
ctmj-52	89	6	,	,	PUNCT
ctmj-52	89	7	vs	vs	ADP
ctmj-52	89	8	control	control	NOUN
ctmj-52	89	9	;	;	PUNCT
ctmj-52	89	10	#	#	SYM
ctmj-52	89	11	#	#	SYM
ctmj-52	89	12	p	p	X
ctmj-52	89	13	<	<	X
ctmj-52	89	14	0.05	0.05	NUM
ctmj-52	89	15	,	,	PUNCT
ctmj-52	89	16	vs	vs	ADP
ctmj-52	89	17	ceruletide	ceruletide	NOUN
ctmj-52	89	18	+	+	CCONJ
ctmj-52	89	19	nc	nc	PROPN
ctmj-52	89	20	overexpression	overexpression	NOUN
ctmj-52	89	21	of	of	ADP
ctmj-52	89	22	march9	march9	NOUN
ctmj-52	89	23	inhibited	inhibited	ADJ
ctmj-52	89	24	inflammation	inflammation	NOUN
ctmj-52	89	25	in	in	ADP
ctmj-52	89	26	ar42j	ar42j	NOUN
ctmj-52	89	27	cells	cell	NOUN
ctmj-52	89	28	induced	induce	VERB
ctmj-52	89	29	by	by	ADP
ctmj-52	89	30	ceruletide	ceruletide	NOUN
ctmj-52	89	31	as	as	SCONJ
ctmj-52	89	32	shown	show	VERB
ctmj-52	89	33	in	in	ADP
ctmj-52	89	34	figure	figure	NOUN
ctmj-52	89	35	3	3	NUM
ctmj-52	89	36	a	a	PRON
ctmj-52	89	37	,	,	PUNCT
ctmj-52	89	38	the	the	DET
ctmj-52	89	39	levels	level	NOUN
ctmj-52	89	40	of	of	ADP
ctmj-52	89	41	inflammatory	inflammatory	ADJ
ctmj-52	89	42	cytokinesin	cytokinesin	NOUN
ctmj-52	89	43	ceruletide	ceruletide	NOUN
ctmj-52	89	44	+	+	CCONJ
ctmj-52	89	45	march9	march9	NOUN
ctmj-52	89	46	group	group	NOUN
ctmj-52	89	47	were	be	AUX
ctmj-52	89	48	remarkably	remarkably	ADV
ctmj-52	89	49	lower	low	ADJ
ctmj-52	89	50	than	than	ADP
ctmj-52	89	51	ceruletide	ceruletide	NOUN
ctmj-52	89	52	+	+	CCONJ
ctmj-52	89	53	nc	nc	PROPN
ctmj-52	89	54	group	group	PROPN
ctmj-52	89	55	(	(	PUNCT
ctmj-52	89	56	p	p	X
ctmj-52	89	57	<	<	X
ctmj-52	89	58	0.05	0.05	NUM
ctmj-52	89	59	)	)	PUNCT
ctmj-52	89	60	.	.	PUNCT
ctmj-52	90	1	tlr4	tlr4	NOUN
ctmj-52	90	2	and	and	CCONJ
ctmj-52	90	3	p	p	NOUN
ctmj-52	90	4	-	-	PUNCT
ctmj-52	90	5	p65	p65	NOUN
ctmj-52	90	6	/	/	SYM
ctmj-52	90	7	p65	p65	NOUN
ctmj-52	90	8	expressions	expression	NOUN
ctmj-52	90	9	were	be	AUX
ctmj-52	90	10	downregulated	downregulate	VERB
ctmj-52	90	11	in	in	ADP
ctmj-52	90	12	ar42j	ar42j	NOUN
ctmj-52	90	13	cells	cell	NOUN
ctmj-52	90	14	induced	induce	VERB
ctmj-52	90	15	by	by	ADP
ctmj-52	90	16	ceruletide	ceruletide	NOUN
ctmj-52	90	17	after	after	ADP
ctmj-52	90	18	transfection	transfection	NOUN
ctmj-52	90	19	with	with	ADP
ctmj-52	90	20	march9	march9	NOUN
ctmj-52	90	21	overexpression	overexpression	NOUN
ctmj-52	90	22	vector	vector	NOUN
ctmj-52	90	23	(	(	PUNCT
ctmj-52	90	24	figure	figure	NOUN
ctmj-52	90	25	3	3	NUM
ctmj-52	90	26	b	b	NOUN
ctmj-52	90	27	)	)	PUNCT
ctmj-52	90	28	.	.	PUNCT
ctmj-52	91	1	chinese	chinese	ADJ
ctmj-52	91	2	traditional	traditional	ADJ
ctmj-52	91	3	medicine	medicine	NOUN
ctmj-52	91	4	journal	journal	NOUN
ctmj-52	91	5	|	|	ADV
ctmj-52	91	6	2020	2020	NUM
ctmj-52	92	1	|	|	ADV
ctmj-52	92	2	vol	vol	NOUN
ctmj-52	92	3	3	3	NUM
ctmj-52	92	4	|	|	ADV
ctmj-52	92	5	issue	issue	VERB
ctmj-52	92	6	5	5	NUM
ctmj-52	92	7	issn	issn	X
ctmj-52	92	8	:	:	PUNCT
ctmj-52	92	9	2693	2693	NUM
ctmj-52	92	10	6356	6356	NUM
ctmj-52	92	11	2020	2020	NUM
ctmj-52	92	12	|	|	ADV
ctmj-52	92	13	vol	vol	NOUN
ctmj-52	92	14	3	3	NUM
ctmj-52	92	15	|	|	ADV
ctmj-52	92	16	issue	issue	VERB
ctmj-52	92	17	5	5	NUM
ctmj-52	92	18	ctmj	ctmj	NOUN
ctmj-52	93	1	|	|	ADV
ctmj-52	93	2	traditionalmedicinejournals.com	traditionalmedicinejournals.com	X
ctmj-52	93	3	figure	figure	NOUN
ctmj-52	93	4	3	3	NUM
ctmj-52	93	5	:	:	PUNCT
ctmj-52	93	6	effect	effect	NOUN
ctmj-52	93	7	of	of	ADP
ctmj-52	93	8	march9	march9	NOUN
ctmj-52	93	9	overexpressed	overexpresse	VERB
ctmj-52	93	10	in	in	ADP
ctmj-52	93	11	inflammation	inflammation	NOUN
ctmj-52	93	12	in	in	ADP
ctmj-52	93	13	ar42j	ar42j	NOUN
ctmj-52	93	14	cells	cell	NOUN
ctmj-52	93	15	induced	induce	VERB
ctmj-52	93	16	by	by	ADP
ctmj-52	93	17	ceruletide	ceruletide	NOUN
ctmj-52	93	18	.	.	PUNCT
ctmj-52	94	1	(	(	PUNCT
ctmj-52	94	2	a	a	X
ctmj-52	94	3	)	)	PUNCT
ctmj-52	94	4	tnf	tnf	PROPN
ctmj-52	94	5	-	-	PUNCT
ctmj-52	94	6	α	α	PROPN
ctmj-52	94	7	,	,	PUNCT
ctmj-52	94	8	il-6	il-6	NUM
ctmj-52	94	9	and	and	CCONJ
ctmj-52	94	10	il-1β	il-1β	PROPN
ctmj-52	94	11	levels	level	NOUN
ctmj-52	94	12	.	.	PUNCT
ctmj-52	95	1	(	(	PUNCT
ctmj-52	95	2	b	b	X
ctmj-52	95	3	)	)	PUNCT
ctmj-52	95	4	tlr4	tlr4	NOUN
ctmj-52	95	5	and	and	CCONJ
ctmj-52	95	6	pp65	pp65	PROPN
ctmj-52	95	7	/	/	SYM
ctmj-52	95	8	p65	p65	NOUN
ctmj-52	95	9	expressions	expression	NOUN
ctmj-52	95	10	.	.	PUNCT
ctmj-52	96	1	*	*	PUNCT
ctmj-52	96	2	*	*	PUNCT
ctmj-52	96	3	*	*	PUNCT
ctmj-52	96	4	p	p	X
ctmj-52	96	5	<	<	X
ctmj-52	96	6	0.05	0.05	NUM
ctmj-52	96	7	or	or	CCONJ
ctmj-52	96	8	*	*	NOUN
ctmj-52	96	9	*	*	PUNCT
ctmj-52	96	10	p	p	X
ctmj-52	96	11	<	<	X
ctmj-52	96	12	0.05	0.05	NUM
ctmj-52	96	13	,	,	PUNCT
ctmj-52	96	14	vs	vs	ADP
ctmj-52	96	15	control	control	NOUN
ctmj-52	96	16	;	;	PUNCT
ctmj-52	96	17	#	#	SYM
ctmj-52	96	18	#	#	SYM
ctmj-52	96	19	p	p	X
ctmj-52	96	20	<	<	X
ctmj-52	96	21	0.05	0.05	NUM
ctmj-52	96	22	or	or	CCONJ
ctmj-52	96	23	#	#	SYM
ctmj-52	96	24	#	#	SYM
ctmj-52	96	25	#	#	SYM
ctmj-52	96	26	p	p	NOUN
ctmj-52	96	27	<	<	X
ctmj-52	96	28	0.05	0.05	NUM
ctmj-52	96	29	,	,	PUNCT
ctmj-52	96	30	vs	vs	ADP
ctmj-52	96	31	ceruletide	ceruletide	NOUN
ctmj-52	96	32	+	+	CCONJ
ctmj-52	96	33	nc	nc	PROPN
ctmj-52	96	34	overexpression	overexpression	NOUN
ctmj-52	96	35	of	of	ADP
ctmj-52	96	36	march9	march9	NOUN
ctmj-52	96	37	inhibited	inhibit	VERB
ctmj-52	96	38	the	the	DET
ctmj-52	96	39	pyroptosis	pyroptosis	NOUN
ctmj-52	96	40	of	of	ADP
ctmj-52	96	41	ar42j	ar42j	NOUN
ctmj-52	96	42	cells	cell	NOUN
ctmj-52	96	43	induced	induce	VERB
ctmj-52	96	44	by	by	ADP
ctmj-52	96	45	ceruletide	ceruletide	NOUN
ctmj-52	96	46	western	western	ADJ
ctmj-52	96	47	blotting	blotting	ADJ
ctmj-52	96	48	results	result	NOUN
ctmj-52	96	49	revealed	reveal	VERB
ctmj-52	96	50	that	that	SCONJ
ctmj-52	96	51	march9	march9	NOUN
ctmj-52	96	52	down	down	ADV
ctmj-52	96	53	-	-	PUNCT
ctmj-52	96	54	regulated	regulate	VERB
ctmj-52	96	55	the	the	DET
ctmj-52	96	56	expressions	expression	NOUN
ctmj-52	96	57	of	of	ADP
ctmj-52	96	58	nlrp3	nlrp3	NOUN
ctmj-52	96	59	,	,	PUNCT
ctmj-52	96	60	gsdmdn	gsdmdn	NOUN
ctmj-52	96	61	,	,	PUNCT
ctmj-52	96	62	caspase	caspase	NOUN
ctmj-52	96	63	1	1	NUM
ctmj-52	96	64	,	,	PUNCT
ctmj-52	96	65	il-1β	il-1β	PROPN
ctmj-52	96	66	and	and	CCONJ
ctmj-52	96	67	il-18	il-18	ADV
ctmj-52	96	68	in	in	ADP
ctmj-52	96	69	ar42j	ar42j	NOUN
ctmj-52	96	70	cells	cell	NOUN
ctmj-52	96	71	induced	induce	VERB
ctmj-52	96	72	by	by	ADP
ctmj-52	96	73	ceruletide	ceruletide	NOUN
ctmj-52	96	74	(	(	PUNCT
ctmj-52	96	75	figure	figure	VERB
ctmj-52	96	76	4	4	NUM
ctmj-52	96	77	a	a	PRON
ctmj-52	96	78	)	)	PUNCT
ctmj-52	96	79	.	.	PUNCT
ctmj-52	97	1	as	as	SCONJ
ctmj-52	97	2	shown	show	VERB
ctmj-52	97	3	in	in	ADP
ctmj-52	97	4	figure	figure	NOUN
ctmj-52	97	5	4	4	NUM
ctmj-52	97	6	b	b	NOUN
ctmj-52	97	7	,	,	PUNCT
ctmj-52	97	8	the	the	DET
ctmj-52	97	9	overexpression	overexpression	NOUN
ctmj-52	97	10	of	of	ADP
ctmj-52	97	11	march9	march9	NOUN
ctmj-52	97	12	regulated	regulate	VERB
ctmj-52	97	13	the	the	DET
ctmj-52	97	14	activity	activity	NOUN
ctmj-52	97	15	of	of	ADP
ctmj-52	97	16	caspase	caspase	PROPN
ctmj-52	97	17	1	1	NUM
ctmj-52	97	18	in	in	ADP
ctmj-52	97	19	ceruletide	ceruletide	NOUN
ctmj-52	97	20	+	+	CCONJ
ctmj-52	97	21	march9	march9	NOUN
ctmj-52	97	22	group	group	NOUN
ctmj-52	97	23	,	,	PUNCT
ctmj-52	97	24	compared	compare	VERB
ctmj-52	97	25	with	with	ADP
ctmj-52	97	26	ceruletide	ceruletide	NOUN
ctmj-52	97	27	+	+	CCONJ
ctmj-52	97	28	nc	nc	PROPN
ctmj-52	97	29	group	group	NOUN
ctmj-52	97	30	.	.	PUNCT
ctmj-52	98	1	over	over	ADP
ctmj-52	98	2	-	-	PUNCT
ctmj-52	98	3	expression	expression	NOUN
ctmj-52	98	4	of	of	ADP
ctmj-52	98	5	march9	march9	NOUN
ctmj-52	98	6	inhibited	inhibit	VERB
ctmj-52	98	7	il6	il6	PROPN
ctmj-52	98	8	/	/	SYM
ctmj-52	98	9	jak	jak	PROPN
ctmj-52	98	10	/	/	SYM
ctmj-52	98	11	sata3	sata3	PROPN
ctmj-52	98	12	pathway	pathway	NOUN
ctmj-52	98	13	to	to	PART
ctmj-52	98	14	further	far	ADV
ctmj-52	98	15	investigate	investigate	VERB
ctmj-52	98	16	the	the	DET
ctmj-52	98	17	regulatory	regulatory	ADJ
ctmj-52	98	18	mechanism	mechanism	NOUN
ctmj-52	98	19	of	of	ADP
ctmj-52	98	20	march9	march9	NOUN
ctmj-52	98	21	in	in	ADP
ctmj-52	98	22	the	the	DET
ctmj-52	98	23	pyroptosis	pyroptosis	NOUN
ctmj-52	98	24	of	of	ADP
ctmj-52	98	25	ar42j	ar42j	NOUN
ctmj-52	98	26	cells	cell	NOUN
ctmj-52	98	27	induced	induce	VERB
ctmj-52	98	28	by	by	ADP
ctmj-52	98	29	ceruletide	ceruletide	NOUN
ctmj-52	98	30	,	,	PUNCT
ctmj-52	98	31	the	the	DET
ctmj-52	98	32	expression	expression	NOUN
ctmj-52	98	33	of	of	ADP
ctmj-52	98	34	related	related	ADJ
ctmj-52	98	35	proteins	protein	NOUN
ctmj-52	98	36	was	be	AUX
ctmj-52	98	37	determined	determine	VERB
ctmj-52	98	38	using	use	VERB
ctmj-52	98	39	western	western	ADJ
ctmj-52	98	40	blotting	blotting	NOUN
ctmj-52	98	41	.	.	PUNCT
ctmj-52	99	1	the	the	DET
ctmj-52	99	2	results	result	NOUN
ctmj-52	99	3	showed	show	VERB
ctmj-52	99	4	that	that	SCONJ
ctmj-52	99	5	march9	march9	NOUN
ctmj-52	99	6	overexpression	overexpression	NOUN
ctmj-52	99	7	repressed	repress	VERB
ctmj-52	99	8	the	the	DET
ctmj-52	99	9	expressions	expression	NOUN
ctmj-52	99	10	of	of	ADP
ctmj-52	99	11	il-6	il-6	NOUN
ctmj-52	99	12	,	,	PUNCT
ctmj-52	99	13	p	p	PROPN
ctmj-52	99	14	-	-	PUNCT
ctmj-52	99	15	jak2	jak2	NOUN
ctmj-52	99	16	/	/	SYM
ctmj-52	99	17	jak2	jak2	PROPN
ctmj-52	99	18	and	and	CCONJ
ctmj-52	99	19	pstat3	pstat3	NOUN
ctmj-52	99	20	/	/	SYM
ctmj-52	99	21	stat3	stat3	NOUN
ctmj-52	99	22	in	in	ADP
ctmj-52	99	23	ar42j	ar42j	NOUN
ctmj-52	99	24	cells	cell	NOUN
ctmj-52	99	25	induced	induce	VERB
ctmj-52	99	26	by	by	ADP
ctmj-52	99	27	ceruletide	ceruletide	NOUN
ctmj-52	99	28	(	(	PUNCT
ctmj-52	99	29	figure	figure	NOUN
ctmj-52	99	30	5	5	NUM
ctmj-52	99	31	)	)	PUNCT
ctmj-52	99	32	.	.	PUNCT
ctmj-52	100	1	figure	figure	VERB
ctmj-52	100	2	4	4	NUM
ctmj-52	100	3	:	:	PUNCT
ctmj-52	100	4	effect	effect	NOUN
ctmj-52	100	5	of	of	ADP
ctmj-52	100	6	march9	march9	NOUN
ctmj-52	100	7	overexpressed	overexpresse	VERB
ctmj-52	100	8	in	in	ADP
ctmj-52	100	9	the	the	DET
ctmj-52	100	10	pyroptosis	pyroptosis	NOUN
ctmj-52	100	11	of	of	ADP
ctmj-52	100	12	ar42j	ar42j	NOUN
ctmj-52	100	13	cells	cell	NOUN
ctmj-52	100	14	induced	induce	VERB
ctmj-52	100	15	by	by	ADP
ctmj-52	100	16	ceruletide	ceruletide	NOUN
ctmj-52	100	17	.	.	PUNCT
ctmj-52	101	1	(	(	PUNCT
ctmj-52	101	2	a	a	X
ctmj-52	101	3	)	)	PUNCT
ctmj-52	101	4	expressions	expression	NOUN
ctmj-52	101	5	of	of	ADP
ctmj-52	101	6	nlrp3	nlrp3	NOUN
ctmj-52	101	7	,	,	PUNCT
ctmj-52	101	8	gsdmd	gsdmd	NOUN
ctmj-52	101	9	-	-	PUNCT
ctmj-52	101	10	n	n	NOUN
ctmj-52	101	11	,	,	PUNCT
ctmj-52	101	12	caspase	caspase	NOUN
ctmj-52	101	13	1	1	NUM
ctmj-52	101	14	,	,	PUNCT
ctmj-52	101	15	il-1β	il-1β	PROPN
ctmj-52	101	16	and	and	CCONJ
ctmj-52	101	17	il-18	il-18	PRON
ctmj-52	101	18	.	.	PUNCT
ctmj-52	102	1	(	(	PUNCT
ctmj-52	102	2	b	b	X
ctmj-52	102	3	)	)	PUNCT
ctmj-52	102	4	activity	activity	NOUN
ctmj-52	102	5	of	of	ADP
ctmj-52	102	6	caspase	caspase	PROPN
ctmj-52	102	7	1	1	NUM
ctmj-52	102	8	.	.	PUNCT
ctmj-52	103	1	p	p	X
ctmj-52	103	2	<	<	X
ctmj-52	103	3	0.05	0.05	NUM
ctmj-52	103	4	,	,	PUNCT
ctmj-52	103	5	vs	vs	ADP
ctmj-52	103	6	control	control	NOUN
ctmj-52	103	7	;	;	PUNCT
ctmj-52	103	8	#	#	SYM
ctmj-52	103	9	#	#	SYM
ctmj-52	103	10	p	p	X
ctmj-52	103	11	<	<	X
ctmj-52	103	12	0.05	0.05	NUM
ctmj-52	103	13	,	,	PUNCT
ctmj-52	103	14	vs	vs	ADP
ctmj-52	103	15	ceruletide	ceruletide	NOUN
ctmj-52	103	16	+	+	CCONJ
ctmj-52	103	17	nc	nc	PROPN
ctmj-52	103	18	figure	figure	NOUN
ctmj-52	103	19	5	5	NUM
ctmj-52	103	20	:	:	PUNCT
ctmj-52	103	21	effect	effect	NOUN
ctmj-52	103	22	of	of	ADP
ctmj-52	103	23	march9	march9	NOUN
ctmj-52	103	24	overexpressed	overexpresse	VERB
ctmj-52	103	25	in	in	ADP
ctmj-52	103	26	il6	il6	PROPN
ctmj-52	103	27	/	/	SYM
ctmj-52	103	28	jak	jak	PROPN
ctmj-52	103	29	/	/	SYM
ctmj-52	103	30	sata3	sata3	PROPN
ctmj-52	103	31	levels	level	NOUN
ctmj-52	103	32	.	.	PUNCT
ctmj-52	104	1	expressions	expression	NOUN
ctmj-52	104	2	of	of	ADP
ctmj-52	104	3	il-6	il-6	NOUN
ctmj-52	104	4	,	,	PUNCT
ctmj-52	104	5	pjak2	pjak2	NOUN
ctmj-52	104	6	/	/	SYM
ctmj-52	104	7	jak2	jak2	NOUN
ctmj-52	104	8	,	,	PUNCT
ctmj-52	104	9	and	and	CCONJ
ctmj-52	104	10	p	p	X
ctmj-52	104	11	-	-	PUNCT
ctmj-52	104	12	stat3	stat3	NOUN
ctmj-52	104	13	/	/	SYM
ctmj-52	104	14	stat3	stat3	NOUN
ctmj-52	104	15	.	.	PUNCT
ctmj-52	105	1	*	*	PUNCT
ctmj-52	106	1	*	*	PUNCT
ctmj-52	106	2	*	*	PUNCT
ctmj-52	106	3	p	p	X
ctmj-52	106	4	<	<	X
ctmj-52	106	5	0.05	0.05	NUM
ctmj-52	106	6	,	,	PUNCT
ctmj-52	106	7	vs	vs	ADP
ctmj-52	106	8	control	control	NOUN
ctmj-52	106	9	;	;	PUNCT
ctmj-52	107	1	#	#	SYM
ctmj-52	107	2	#	#	SYM
ctmj-52	107	3	#	#	SYM
ctmj-52	107	4	p	p	NOUN
ctmj-52	107	5	<	<	X
ctmj-52	107	6	0.05	0.05	NUM
ctmj-52	107	7	or	or	CCONJ
ctmj-52	107	8	#	#	SYM
ctmj-52	107	9	#	#	SYM
ctmj-52	107	10	p	p	X
ctmj-52	107	11	<	<	X
ctmj-52	107	12	0.05	0.05	NUM
ctmj-52	107	13	,	,	PUNCT
ctmj-52	107	14	vs	vs	ADP
ctmj-52	107	15	ceruletide	ceruletide	NOUN
ctmj-52	107	16	+	+	CCONJ
ctmj-52	107	17	nc	nc	PROPN
ctmj-52	107	18	discussion	discussion	NOUN
ctmj-52	107	19	recent	recent	ADJ
ctmj-52	107	20	studies	study	NOUN
ctmj-52	107	21	showed	show	VERB
ctmj-52	107	22	that	that	SCONJ
ctmj-52	107	23	inhibiting	inhibit	VERB
ctmj-52	107	24	pyroptosis	pyroptosis	NOUN
ctmj-52	107	25	alleviates	alleviate	VERB
ctmj-52	107	26	pancreatic	pancreatic	ADJ
ctmj-52	107	27	injury	injury	NOUN
ctmj-52	107	28	and	and	CCONJ
ctmj-52	107	29	significantly	significantly	ADV
ctmj-52	107	30	affects	affect	VERB
ctmj-52	107	31	the	the	DET
ctmj-52	107	32	progression	progression	NOUN
ctmj-52	107	33	of	of	ADP
ctmj-52	107	34	ap	ap	PROPN
ctmj-52	108	1	[	[	X
ctmj-52	108	2	12	12	NUM
ctmj-52	108	3	]	]	PUNCT
ctmj-52	108	4	.	.	PUNCT
ctmj-52	109	1	this	this	DET
ctmj-52	109	2	study	study	NOUN
ctmj-52	109	3	showed	show	VERB
ctmj-52	109	4	that	that	SCONJ
ctmj-52	109	5	march9	march9	NOUN
ctmj-52	109	6	expression	expression	NOUN
ctmj-52	109	7	is	be	AUX
ctmj-52	109	8	downregulated	downregulate	VERB
ctmj-52	109	9	in	in	ADP
ctmj-52	109	10	ap	ap	PROPN
ctmj-52	109	11	patients	patient	NOUN
ctmj-52	109	12	'	'	PART
ctmj-52	109	13	serum	serum	NOUN
ctmj-52	109	14	and	and	CCONJ
ctmj-52	109	15	has	have	VERB
ctmj-52	109	16	the	the	DET
ctmj-52	109	17	ability	ability	NOUN
ctmj-52	109	18	to	to	PART
ctmj-52	109	19	regulate	regulate	VERB
ctmj-52	109	20	pyroptosis	pyroptosis	NOUN
ctmj-52	109	21	in	in	ADP
ctmj-52	109	22	pa	pa	PROPN
ctmj-52	109	23	cells	cell	NOUN
ctmj-52	109	24	.	.	PUNCT
ctmj-52	110	1	research	research	NOUN
ctmj-52	110	2	has	have	AUX
ctmj-52	110	3	shown	show	VERB
ctmj-52	110	4	that	that	SCONJ
ctmj-52	110	5	march9	march9	NOUN
ctmj-52	110	6	participates	participate	VERB
ctmj-52	110	7	in	in	ADP
ctmj-52	110	8	cancer	cancer	NOUN
ctmj-52	110	9	progression	progression	NOUN
ctmj-52	110	10	.	.	PUNCT
ctmj-52	111	1	in	in	ADP
ctmj-52	111	2	lung	lung	NOUN
ctmj-52	111	3	adenocarcinoma	adenocarcinoma	NOUN
ctmj-52	111	4	,	,	PUNCT
ctmj-52	111	5	the	the	DET
ctmj-52	111	6	overexpression	overexpression	NOUN
ctmj-52	111	7	of	of	ADP
ctmj-52	111	8	march9	march9	NOUN
ctmj-52	111	9	attenuates	attenuate	VERB
ctmj-52	111	10	the	the	DET
ctmj-52	111	11	carcinogenic	carcinogenic	ADJ
ctmj-52	111	12	effect	effect	NOUN
ctmj-52	111	13	of	of	ADP
ctmj-52	111	14	intercellular	intercellular	ADJ
ctmj-52	111	15	adhesion	adhesion	NOUN
ctmj-52	111	16	molecule	molecule	NOUN
ctmj-52	111	17	1	1	NUM
ctmj-52	111	18	(	(	PUNCT
ctmj-52	111	19	icam-1	icam-1	X
ctmj-52	111	20	)	)	PUNCT
ctmj-52	112	1	[	[	X
ctmj-52	112	2	13	13	NUM
ctmj-52	112	3	]	]	PUNCT
ctmj-52	112	4	.	.	PUNCT
ctmj-52	113	1	furthermore	furthermore	ADV
ctmj-52	113	2	,	,	PUNCT
ctmj-52	113	3	studies	study	NOUN
ctmj-52	113	4	have	have	AUX
ctmj-52	113	5	found	find	VERB
ctmj-52	113	6	that	that	SCONJ
ctmj-52	113	7	march9	march9	NOUN
ctmj-52	113	8	is	be	AUX
ctmj-52	113	9	related	relate	VERB
ctmj-52	113	10	to	to	ADP
ctmj-52	113	11	immune	immune	ADJ
ctmj-52	113	12	regulation	regulation	NOUN
ctmj-52	113	13	in	in	ADP
ctmj-52	113	14	the	the	DET
ctmj-52	113	15	chinese	chinese	ADJ
ctmj-52	113	16	traditional	traditional	ADJ
ctmj-52	113	17	medicine	medicine	NOUN
ctmj-52	113	18	journal	journal	NOUN
ctmj-52	113	19	|	|	ADV
ctmj-52	113	20	2020	2020	NUM
ctmj-52	114	1	|	|	ADV
ctmj-52	114	2	vol	vol	NOUN
ctmj-52	114	3	3	3	NUM
ctmj-52	114	4	|	|	ADV
ctmj-52	114	5	issue	issue	VERB
ctmj-52	114	6	5	5	NUM
ctmj-52	114	7	issn	issn	X
ctmj-52	114	8	:	:	PUNCT
ctmj-52	114	9	2693	2693	NUM
ctmj-52	114	10	6356	6356	NUM
ctmj-52	114	11	2020	2020	NUM
ctmj-52	114	12	|	|	ADV
ctmj-52	114	13	vol	vol	NOUN
ctmj-52	114	14	3	3	NUM
ctmj-52	114	15	|	|	ADV
ctmj-52	114	16	issue	issue	VERB
ctmj-52	114	17	5	5	NUM
ctmj-52	114	18	ctmj	ctmj	NOUN
ctmj-52	115	1	|	|	ADV
ctmj-52	115	2	traditionalmedicinejournals.com	traditionalmedicinejournals.com	X
ctmj-52	115	3	bod	bod	NOUN
ctmj-52	116	1	[	[	X
ctmj-52	116	2	9	9	NUM
ctmj-52	116	3	]	]	PUNCT
ctmj-52	116	4	,	,	PUNCT
ctmj-52	117	1	and	and	CCONJ
ctmj-52	117	2	participates	participate	VERB
ctmj-52	117	3	in	in	ADP
ctmj-52	117	4	innate	innate	ADJ
ctmj-52	117	5	immunity	immunity	NOUN
ctmj-52	117	6	by	by	ADP
ctmj-52	117	7	catalyzing	catalyze	VERB
ctmj-52	117	8	the	the	DET
ctmj-52	117	9	polyubiquitination	polyubiquitination	NOUN
ctmj-52	117	10	of	of	ADP
ctmj-52	117	11	key	key	ADJ
ctmj-52	117	12	immune	immune	ADJ
ctmj-52	117	13	factors	factor	NOUN
ctmj-52	117	14	[	[	X
ctmj-52	117	15	14	14	NUM
ctmj-52	117	16	]	]	PUNCT
ctmj-52	117	17	.	.	PUNCT
ctmj-52	118	1	another	another	DET
ctmj-52	118	2	recent	recent	ADJ
ctmj-52	118	3	study	study	NOUN
ctmj-52	118	4	found	find	VERB
ctmj-52	118	5	that	that	SCONJ
ctmj-52	118	6	march9	march9	NOUN
ctmj-52	118	7	was	be	AUX
ctmj-52	118	8	related	relate	VERB
ctmj-52	118	9	to	to	ADP
ctmj-52	118	10	the	the	DET
ctmj-52	118	11	occurrence	occurrence	NOUN
ctmj-52	118	12	of	of	ADP
ctmj-52	118	13	ap	ap	PROPN
ctmj-52	118	14	and	and	CCONJ
ctmj-52	118	15	the	the	DET
ctmj-52	118	16	overexpression	overexpression	NOUN
ctmj-52	118	17	of	of	ADP
ctmj-52	118	18	march9	march9	NOUN
ctmj-52	118	19	inhibits	inhibit	VERB
ctmj-52	118	20	the	the	DET
ctmj-52	118	21	nlrp3	nlrp3	ADJ
ctmj-52	118	22	inflammasome	inflammasome	NOUN
ctmj-52	118	23	-	-	PUNCT
ctmj-52	118	24	dependent	dependent	ADJ
ctmj-52	118	25	pancreatic	pancreatic	ADJ
ctmj-52	118	26	cell	cell	NOUN
ctmj-52	118	27	pyroptosis	pyroptosis	NOUN
ctmj-52	118	28	by	by	ADP
ctmj-52	118	29	mediating	mediate	VERB
ctmj-52	118	30	the	the	DET
ctmj-52	118	31	ubiquitination	ubiquitination	NOUN
ctmj-52	118	32	of	of	ADP
ctmj-52	118	33	nadph	nadph	ADJ
ctmj-52	118	34	oxidase2	oxidase2	NOUN
ctmj-52	118	35	,	,	PUNCT
ctmj-52	118	36	which	which	PRON
ctmj-52	118	37	may	may	AUX
ctmj-52	118	38	regulate	regulate	VERB
ctmj-52	118	39	the	the	DET
ctmj-52	118	40	progression	progression	NOUN
ctmj-52	118	41	of	of	ADP
ctmj-52	118	42	ap	ap	PROPN
ctmj-52	119	1	[	[	X
ctmj-52	119	2	10	10	NUM
ctmj-52	119	3	]	]	PUNCT
ctmj-52	119	4	.	.	PUNCT
ctmj-52	120	1	the	the	DET
ctmj-52	120	2	nlrp3	nlrp3	ADJ
ctmj-52	120	3	inflammasome	inflammasome	NOUN
ctmj-52	120	4	is	be	AUX
ctmj-52	120	5	involved	involve	VERB
ctmj-52	120	6	in	in	ADP
ctmj-52	120	7	regulating	regulate	VERB
ctmj-52	120	8	cellular	cellular	ADJ
ctmj-52	120	9	inflammatory	inflammatory	ADJ
ctmj-52	120	10	responses	response	NOUN
ctmj-52	120	11	through	through	ADP
ctmj-52	120	12	the	the	DET
ctmj-52	120	13	modulation	modulation	NOUN
ctmj-52	120	14	of	of	ADP
ctmj-52	120	15	downstream	downstream	ADJ
ctmj-52	120	16	pro	pro	ADJ
ctmj-52	120	17	-	-	ADJ
ctmj-52	120	18	inflammatory	inflammatory	ADJ
ctmj-52	120	19	factors	factor	NOUN
ctmj-52	120	20	[	[	X
ctmj-52	120	21	15	15	NUM
ctmj-52	120	22	]	]	PUNCT
ctmj-52	120	23	.	.	PUNCT
ctmj-52	121	1	one	one	NUM
ctmj-52	121	2	way	way	NOUN
ctmj-52	121	3	to	to	PART
ctmj-52	121	4	effectively	effectively	ADV
ctmj-52	121	5	mitigate	mitigate	VERB
ctmj-52	121	6	these	these	DET
ctmj-52	121	7	inflammatory	inflammatory	ADJ
ctmj-52	121	8	responses	response	NOUN
ctmj-52	121	9	is	be	AUX
ctmj-52	121	10	to	to	PART
ctmj-52	121	11	target	target	VERB
ctmj-52	121	12	nlrp3	nlrp3	NOUN
ctmj-52	122	1	[	[	X
ctmj-52	122	2	16	16	NUM
ctmj-52	122	3	]	]	PUNCT
ctmj-52	122	4	.	.	PUNCT
ctmj-52	123	1	in	in	ADP
ctmj-52	123	2	addition	addition	NOUN
ctmj-52	123	3	,	,	PUNCT
ctmj-52	123	4	nlrp3	nlrp3	NOUN
ctmj-52	123	5	is	be	AUX
ctmj-52	123	6	also	also	ADV
ctmj-52	123	7	closely	closely	ADV
ctmj-52	123	8	related	relate	VERB
ctmj-52	123	9	to	to	ADP
ctmj-52	123	10	the	the	DET
ctmj-52	123	11	occurrence	occurrence	NOUN
ctmj-52	123	12	of	of	ADP
ctmj-52	123	13	pyroptosis	pyroptosis	NOUN
ctmj-52	123	14	.	.	PUNCT
ctmj-52	124	1	for	for	ADP
ctmj-52	124	2	example	example	NOUN
ctmj-52	124	3	,	,	PUNCT
ctmj-52	124	4	isoliquiritin	isoliquiritin	ADJ
ctmj-52	124	5	ameliorates	ameliorate	NOUN
ctmj-52	124	6	depression	depression	NOUN
ctmj-52	124	7	symptoms	symptom	NOUN
ctmj-52	124	8	by	by	ADP
ctmj-52	124	9	suppressing	suppress	VERB
ctmj-52	124	10	mirna-27a	mirna-27a	PROPN
ctmj-52	124	11	-	-	PUNCT
ctmj-52	124	12	mediated	mediate	VERB
ctmj-52	124	13	pyroptosis	pyroptosis	NOUN
ctmj-52	124	14	induced	induce	VERB
ctmj-52	124	15	via	via	ADP
ctmj-52	124	16	nlrp3	nlrp3	ADJ
ctmj-52	124	17	inhibition	inhibition	NOUN
ctmj-52	124	18	[	[	X
ctmj-52	124	19	17	17	NUM
ctmj-52	124	20	]	]	PUNCT
ctmj-52	124	21	.	.	PUNCT
ctmj-52	125	1	furthermore	furthermore	ADV
ctmj-52	125	2	,	,	PUNCT
ctmj-52	125	3	cisplatin	cisplatin	NOUN
ctmj-52	125	4	activates	activate	VERB
ctmj-52	125	5	nlrp3	nlrp3	NOUN
ctmj-52	125	6	/	/	SYM
ctmj-52	125	7	caspase	caspase	NOUN
ctmj-52	125	8	1	1	NUM
ctmj-52	125	9	pathway	pathway	NOUN
ctmj-52	125	10	,	,	PUNCT
ctmj-52	125	11	contributing	contribute	VERB
ctmj-52	125	12	to	to	ADP
ctmj-52	125	13	trigger	trigger	NOUN
ctmj-52	125	14	pyroptosis	pyroptosis	NOUN
ctmj-52	125	15	in	in	ADP
ctmj-52	125	16	triple	triple	ADJ
ctmj-52	125	17	-	-	PUNCT
ctmj-52	125	18	negative	negative	ADJ
ctmj-52	125	19	breast	breast	NOUN
ctmj-52	125	20	cancer	cancer	NOUN
ctmj-52	125	21	cells	cell	NOUN
ctmj-52	125	22	[	[	X
ctmj-52	125	23	18	18	NUM
ctmj-52	125	24	]	]	PUNCT
ctmj-52	125	25	.	.	PUNCT
ctmj-52	126	1	in	in	ADP
ctmj-52	126	2	the	the	DET
ctmj-52	126	3	present	present	ADJ
ctmj-52	126	4	study	study	NOUN
ctmj-52	126	5	,	,	PUNCT
ctmj-52	126	6	march9	march9	NOUN
ctmj-52	126	7	was	be	AUX
ctmj-52	126	8	lowly	lowly	ADV
ctmj-52	126	9	expressed	express	VERB
ctmj-52	126	10	in	in	ADP
ctmj-52	126	11	the	the	DET
ctmj-52	126	12	serum	serum	NOUN
ctmj-52	126	13	of	of	ADP
ctmj-52	126	14	ap	ap	PROPN
ctmj-52	126	15	patients	patient	NOUN
ctmj-52	126	16	,	,	PUNCT
ctmj-52	126	17	which	which	PRON
ctmj-52	126	18	suggests	suggest	VERB
ctmj-52	126	19	that	that	SCONJ
ctmj-52	126	20	march9	march9	NOUN
ctmj-52	126	21	was	be	AUX
ctmj-52	126	22	related	relate	VERB
ctmj-52	126	23	to	to	ADP
ctmj-52	126	24	the	the	DET
ctmj-52	126	25	development	development	NOUN
ctmj-52	126	26	of	of	ADP
ctmj-52	126	27	ap	ap	PROPN
ctmj-52	126	28	.	.	PUNCT
ctmj-52	127	1	to	to	PART
ctmj-52	127	2	further	far	ADV
ctmj-52	127	3	explore	explore	VERB
ctmj-52	127	4	the	the	DET
ctmj-52	127	5	role	role	NOUN
ctmj-52	127	6	of	of	ADP
ctmj-52	127	7	march9	march9	NOUN
ctmj-52	127	8	in	in	ADP
ctmj-52	127	9	ap	ap	PROPN
ctmj-52	127	10	,	,	PUNCT
ctmj-52	127	11	an	an	DET
ctmj-52	127	12	in	in	ADP
ctmj-52	127	13	vitro	vitro	X
ctmj-52	127	14	ap	ap	PROPN
ctmj-52	127	15	cell	cell	NOUN
ctmj-52	127	16	model	model	NOUN
ctmj-52	127	17	was	be	AUX
ctmj-52	127	18	established	establish	VERB
ctmj-52	127	19	by	by	ADP
ctmj-52	127	20	inducing	induce	VERB
ctmj-52	127	21	pa	pa	PROPN
ctmj-52	127	22	cells	cell	NOUN
ctmj-52	127	23	with	with	ADP
ctmj-52	127	24	ceruletide	ceruletide	NOUN
ctmj-52	127	25	and	and	CCONJ
ctmj-52	127	26	investigated	investigate	VERB
ctmj-52	127	27	for	for	ADP
ctmj-52	127	28	its	its	PRON
ctmj-52	127	29	effect	effect	NOUN
ctmj-52	127	30	on	on	ADP
ctmj-52	127	31	pa	pa	PROPN
ctmj-52	127	32	cells	cell	NOUN
ctmj-52	127	33	pyroptosis	pyroptosis	NOUN
ctmj-52	127	34	by	by	ADP
ctmj-52	127	35	overexpressing	overexpresse	VERB
ctmj-52	127	36	march9	march9	NOUN
ctmj-52	127	37	.	.	PUNCT
ctmj-52	128	1	as	as	SCONJ
ctmj-52	128	2	expected	expect	VERB
ctmj-52	128	3	,	,	PUNCT
ctmj-52	128	4	the	the	DET
ctmj-52	128	5	upregulation	upregulation	NOUN
ctmj-52	128	6	of	of	ADP
ctmj-52	128	7	march9	march9	NOUN
ctmj-52	128	8	suppressed	suppress	VERB
ctmj-52	128	9	the	the	DET
ctmj-52	128	10	inflammation	inflammation	NOUN
ctmj-52	128	11	in	in	ADP
ctmj-52	128	12	ceruletide	ceruletide	NOUN
ctmj-52	128	13	-	-	PUNCT
ctmj-52	128	14	induced	induce	VERB
ctmj-52	128	15	pa	pa	PROPN
ctmj-52	128	16	cells	cell	NOUN
ctmj-52	128	17	,	,	PUNCT
ctmj-52	128	18	as	as	ADV
ctmj-52	128	19	well	well	ADV
ctmj-52	128	20	as	as	ADP
ctmj-52	128	21	nlrp3	nlrp3	ADJ
ctmj-52	128	22	inflammasome	inflammasome	NOUN
ctmj-52	128	23	-	-	PUNCT
ctmj-52	128	24	mediated	mediate	VERB
ctmj-52	128	25	pyroptosis	pyroptosis	NOUN
ctmj-52	128	26	,	,	PUNCT
ctmj-52	128	27	leading	lead	VERB
ctmj-52	128	28	to	to	ADP
ctmj-52	128	29	enhanced	enhanced	ADJ
ctmj-52	128	30	viability	viability	NOUN
ctmj-52	128	31	of	of	ADP
ctmj-52	128	32	the	the	DET
ctmj-52	128	33	pa	pa	PROPN
ctmj-52	128	34	cells	cell	NOUN
ctmj-52	128	35	.	.	PUNCT
ctmj-52	129	1	in	in	ADP
ctmj-52	129	2	addition	addition	NOUN
ctmj-52	129	3	,	,	PUNCT
ctmj-52	129	4	this	this	DET
ctmj-52	129	5	study	study	NOUN
ctmj-52	129	6	revealed	reveal	VERB
ctmj-52	129	7	a	a	DET
ctmj-52	129	8	potential	potential	ADJ
ctmj-52	129	9	association	association	NOUN
ctmj-52	129	10	between	between	ADP
ctmj-52	129	11	march9	march9	NOUN
ctmj-52	129	12	and	and	CCONJ
ctmj-52	129	13	the	the	DET
ctmj-52	129	14	il6	il6	PROPN
ctmj-52	129	15	/	/	SYM
ctmj-52	129	16	jak	jak	PROPN
ctmj-52	129	17	/	/	SYM
ctmj-52	129	18	stat3	stat3	NOUN
ctmj-52	129	19	pathway	pathway	NOUN
ctmj-52	129	20	.	.	PUNCT
ctmj-52	130	1	however	however	ADV
ctmj-52	130	2	,	,	PUNCT
ctmj-52	130	3	this	this	DET
ctmj-52	130	4	study	study	NOUN
ctmj-52	130	5	is	be	AUX
ctmj-52	130	6	only	only	ADV
ctmj-52	130	7	a	a	DET
ctmj-52	130	8	preliminary	preliminary	ADJ
ctmj-52	130	9	work	work	NOUN
ctmj-52	130	10	at	at	ADP
ctmj-52	130	11	the	the	DET
ctmj-52	130	12	cellular	cellular	ADJ
ctmj-52	130	13	level	level	NOUN
ctmj-52	130	14	and	and	CCONJ
ctmj-52	130	15	has	have	AUX
ctmj-52	130	16	not	not	PART
ctmj-52	130	17	been	be	AUX
ctmj-52	130	18	validated	validate	VERB
ctmj-52	130	19	in	in	ADP
ctmj-52	130	20	animal	animal	NOUN
ctmj-52	130	21	models	model	NOUN
ctmj-52	130	22	.	.	PUNCT
ctmj-52	131	1	we	we	PRON
ctmj-52	131	2	will	will	AUX
ctmj-52	131	3	supplement	supplement	VERB
ctmj-52	131	4	this	this	PRON
ctmj-52	131	5	in	in	ADP
ctmj-52	131	6	the	the	DET
ctmj-52	131	7	follow	follow	VERB
ctmj-52	131	8	-	-	PUNCT
ctmj-52	131	9	up	up	ADP
ctmj-52	131	10	study	study	NOUN
ctmj-52	131	11	.	.	PUNCT
ctmj-52	132	1	conclusion	conclusion	NOUN
ctmj-52	132	2	the	the	DET
ctmj-52	132	3	results	result	NOUN
ctmj-52	132	4	confirm	confirm	VERB
ctmj-52	132	5	that	that	DET
ctmj-52	132	6	march9	march9	NOUN
ctmj-52	132	7	is	be	AUX
ctmj-52	132	8	low	low	ADV
ctmj-52	132	9	expressed	express	VERB
ctmj-52	132	10	in	in	ADP
ctmj-52	132	11	ap	ap	PROPN
ctmj-52	132	12	patients	patient	NOUN
ctmj-52	132	13	and	and	CCONJ
ctmj-52	132	14	its	its	PRON
ctmj-52	132	15	overexpression	overexpression	NOUN
ctmj-52	132	16	contributes	contribute	VERB
ctmj-52	132	17	to	to	ADP
ctmj-52	132	18	the	the	DET
ctmj-52	132	19	inhibition	inhibition	NOUN
ctmj-52	132	20	of	of	ADP
ctmj-52	132	21	nlrp3	nlrp3	NOUN
ctmj-52	132	22	-	-	PUNCT
ctmj-52	132	23	induced	induce	VERB
ctmj-52	132	24	pyroptosis	pyroptosis	NOUN
ctmj-52	132	25	in	in	ADP
ctmj-52	132	26	pa	pa	PROPN
ctmj-52	132	27	cells	cell	NOUN
ctmj-52	132	28	by	by	ADP
ctmj-52	132	29	regulating	regulate	VERB
ctmj-52	132	30	il6	il6	PROPN
ctmj-52	132	31	/	/	SYM
ctmj-52	132	32	jak	jak	PROPN
ctmj-52	132	33	/	/	SYM
ctmj-52	132	34	stat3	stat3	NOUN
ctmj-52	132	35	pathway	pathway	NOUN
ctmj-52	132	36	.	.	PUNCT
ctmj-52	133	1	thus	thus	ADV
ctmj-52	133	2	,	,	PUNCT
ctmj-52	133	3	march9	march9	NOUN
ctmj-52	133	4	is	be	AUX
ctmj-52	133	5	a	a	DET
ctmj-52	133	6	potential	potential	ADJ
ctmj-52	133	7	biomarker	biomarker	NOUN
ctmj-52	133	8	for	for	ADP
ctmj-52	133	9	ap	ap	PROPN
ctmj-52	133	10	treatment	treatment	PROPN
ctmj-52	133	11	.	.	PUNCT
ctmj-52	134	1	references	reference	NOUN
ctmj-52	134	2	1	1	NUM
ctmj-52	134	3	.	.	PUNCT
ctmj-52	135	1	cheng	cheng	PROPN
ctmj-52	135	2	z	z	PROPN
ctmj-52	135	3	,	,	PUNCT
ctmj-52	135	4	abrams	abrams	PROPN
ctmj-52	135	5	st	st	PROPN
ctmj-52	135	6	,	,	PUNCT
ctmj-52	135	7	alhamdi	alhamdi	PROPN
ctmj-52	135	8	y	y	PROPN
ctmj-52	135	9	,	,	PUNCT
ctmj-52	135	10	toh	toh	PROPN
ctmj-52	135	11	j	j	PROPN
ctmj-52	135	12	,	,	PUNCT
ctmj-52	135	13	yu	yu	PROPN
ctmj-52	135	14	w	w	PROPN
ctmj-52	135	15	,	,	PUNCT
ctmj-52	135	16	wang	wang	PROPN
ctmj-52	135	17	g	g	PROPN
ctmj-52	135	18	,	,	PUNCT
ctmj-52	135	19	toh	toh	PROPN
ctmj-52	135	20	ch	ch	NOUN
ctmj-52	135	21	.	.	PUNCT
ctmj-52	136	1	circulating	circulate	VERB
ctmj-52	136	2	histones	histone	NOUN
ctmj-52	136	3	are	be	AUX
ctmj-52	136	4	major	major	ADJ
ctmj-52	136	5	mediators	mediator	NOUN
ctmj-52	136	6	of	of	ADP
ctmj-52	136	7	multiple	multiple	ADJ
ctmj-52	136	8	organ	organ	NOUN
ctmj-52	136	9	dysfunction	dysfunction	NOUN
ctmj-52	136	10	syndrome	syndrome	NOUN
ctmj-52	136	11	in	in	ADP
ctmj-52	136	12	acute	acute	ADJ
ctmj-52	136	13	critical	critical	ADJ
ctmj-52	136	14	illnesses	illness	NOUN
ctmj-52	136	15	.	.	PUNCT
ctmj-52	137	1	crit	crit	PROPN
ctmj-52	137	2	care	care	PROPN
ctmj-52	137	3	med	me	VERB
ctmj-52	137	4	2019	2019	NUM
ctmj-52	137	5	;	;	PUNCT
ctmj-52	137	6	47(8	47(8	NOUN
ctmj-52	137	7	):	):	PUNCT
ctmj-52	137	8	e677	e677	PROPN
ctmj-52	137	9	-	-	PUNCT
ctmj-52	137	10	e684	e684	PROPN
ctmj-52	137	11	.	.	PROPN
ctmj-52	138	1	2	2	NUM
ctmj-52	138	2	.	.	X
ctmj-52	138	3	mayerle	mayerle	PROPN
ctmj-52	138	4	j	j	PROPN
ctmj-52	138	5	,	,	PUNCT
ctmj-52	138	6	sendler	sendler	PROPN
ctmj-52	138	7	m	m	PROPN
ctmj-52	138	8	,	,	PUNCT
ctmj-52	138	9	hegyi	hegyi	PROPN
ctmj-52	138	10	e	e	NOUN
ctmj-52	138	11	,	,	PUNCT
ctmj-52	138	12	beyer	beyer	PROPN
ctmj-52	138	13	g	g	PROPN
ctmj-52	138	14	,	,	PUNCT
ctmj-52	138	15	lerch	lerch	PROPN
ctmj-52	138	16	mm	mm	PROPN
ctmj-52	138	17	,	,	PUNCT
ctmj-52	138	18	sahin	sahin	PROPN
ctmj-52	138	19	-	-	PUNCT
ctmj-52	138	20	tóth	tóth	PROPN
ctmj-52	138	21	m.	m.	NOUN
ctmj-52	138	22	genetics	genetic	NOUN
ctmj-52	138	23	,	,	PUNCT
ctmj-52	138	24	cell	cell	NOUN
ctmj-52	138	25	biology	biology	NOUN
ctmj-52	138	26	,	,	PUNCT
ctmj-52	138	27	and	and	CCONJ
ctmj-52	138	28	pathophysiology	pathophysiology	NOUN
ctmj-52	138	29	of	of	ADP
ctmj-52	138	30	pancreatitis	pancreatitis	PROPN
ctmj-52	138	31	.	.	PUNCT
ctmj-52	139	1	gastroenterology	gastroenterology	NOUN
ctmj-52	139	2	2019	2019	NUM
ctmj-52	139	3	;	;	PUNCT
ctmj-52	139	4	156(7	156(7	NUM
ctmj-52	139	5	):	):	PUNCT
ctmj-52	139	6	1951	1951	NUM
ctmj-52	139	7	-	-	SYM
ctmj-52	139	8	1968.e1951	1968.e1951	NOUN
ctmj-52	139	9	.	.	PUNCT
ctmj-52	140	1	3	3	X
ctmj-52	140	2	.	.	X
ctmj-52	140	3	pasari	pasari	ADJ
ctmj-52	140	4	lp	lp	PROPN
ctmj-52	140	5	,	,	PUNCT
ctmj-52	140	6	khurana	khurana	PROPN
ctmj-52	140	7	a	a	PRON
ctmj-52	140	8	,	,	PUNCT
ctmj-52	140	9	anchi	anchi	NOUN
ctmj-52	140	10	p	p	NOUN
ctmj-52	140	11	,	,	PUNCT
ctmj-52	140	12	aslam	aslam	PROPN
ctmj-52	140	13	saifi	saifi	PROPN
ctmj-52	140	14	m	m	PROPN
ctmj-52	140	15	,	,	PUNCT
ctmj-52	140	16	annaldas	annaldas	PROPN
ctmj-52	140	17	s	s	PART
ctmj-52	140	18	,	,	PUNCT
ctmj-52	140	19	godugu	godugu	ADJ
ctmj-52	140	20	c.	c.	PROPN
ctmj-52	140	21	visnagin	visnagin	PROPN
ctmj-52	140	22	attenuates	attenuate	VERB
ctmj-52	140	23	acute	acute	PROPN
ctmj-52	140	24	pancreatitis	pancreatitis	PROPN
ctmj-52	140	25	via	via	ADP
ctmj-52	140	26	nrf2	nrf2	PROPN
ctmj-52	140	27	/	/	SYM
ctmj-52	140	28	nfκb	nfκb	NOUN
ctmj-52	140	29	pathway	pathway	NOUN
ctmj-52	140	30	and	and	CCONJ
ctmj-52	140	31	abrogates	abrogate	VERB
ctmj-52	140	32	associated	associate	VERB
ctmj-52	140	33	multiple	multiple	ADJ
ctmj-52	140	34	organ	organ	NOUN
ctmj-52	140	35	dysfunction	dysfunction	NOUN
ctmj-52	140	36	.	.	PUNCT
ctmj-52	141	1	biomed	biome	VERB
ctmj-52	141	2	pharmacother	pharmacother	ADJ
ctmj-52	141	3	2019	2019	NUM
ctmj-52	141	4	;	;	PUNCT
ctmj-52	141	5	112(108629	112(108629	NUM
ctmj-52	141	6	.	.	X
ctmj-52	142	1	4	4	NUM
ctmj-52	142	2	.	.	X
ctmj-52	142	3	zhang	zhang	PROPN
ctmj-52	142	4	x	x	PROPN
ctmj-52	142	5	,	,	PUNCT
ctmj-52	142	6	chen	chen	PROPN
ctmj-52	142	7	w	w	PROPN
ctmj-52	142	8	,	,	PUNCT
ctmj-52	142	9	liu	liu	PROPN
ctmj-52	142	10	w	w	PROPN
ctmj-52	142	11	,	,	PUNCT
ctmj-52	142	12	li	li	PROPN
ctmj-52	142	13	d	d	PROPN
ctmj-52	142	14	,	,	PUNCT
ctmj-52	142	15	shen	shen	PROPN
ctmj-52	142	16	w.	w.	PROPN
ctmj-52	142	17	cited2	cited2	PROPN
ctmj-52	142	18	alleviates	alleviate	VERB
ctmj-52	142	19	lipopolysaccharide	lipopolysaccharide	ADV
ctmj-52	142	20	-	-	PUNCT
ctmj-52	142	21	induced	induce	VERB
ctmj-52	142	22	inflammation	inflammation	NOUN
ctmj-52	142	23	and	and	CCONJ
ctmj-52	142	24	pyroptosis	pyroptosis	NOUN
ctmj-52	142	25	in	in	ADP
ctmj-52	142	26	human	human	ADJ
ctmj-52	142	27	lung	lung	NOUN
ctmj-52	142	28	fibroblast	fibroblast	NOUN
ctmj-52	142	29	by	by	ADP
ctmj-52	142	30	inhibition	inhibition	NOUN
ctmj-52	142	31	of	of	ADP
ctmj-52	142	32	nf	nf	ADJ
ctmj-52	142	33	-	-	PUNCT
ctmj-52	142	34	κb	κb	NOUN
ctmj-52	142	35	pathway	pathway	NOUN
ctmj-52	142	36	.	.	PUNCT
ctmj-52	143	1	allergol	allergol	PROPN
ctmj-52	143	2	immunopathol	immunopathol	PROPN
ctmj-52	143	3	(	(	PUNCT
ctmj-52	143	4	madr	madr	PROPN
ctmj-52	143	5	)	)	PUNCT
ctmj-52	143	6	2022	2022	NUM
ctmj-52	143	7	;	;	PUNCT
ctmj-52	143	8	50(4	50(4	NUM
ctmj-52	143	9	):	):	PUNCT
ctmj-52	143	10	64	64	NUM
ctmj-52	143	11	-	-	SYM
ctmj-52	143	12	70	70	NUM
ctmj-52	143	13	.	.	PUNCT
ctmj-52	144	1	5	5	NUM
ctmj-52	144	2	.	.	X
ctmj-52	144	3	buranrat	buranrat	PROPN
ctmj-52	144	4	b	b	PROPN
ctmj-52	144	5	,	,	PUNCT
ctmj-52	144	6	prawan	prawan	PROPN
ctmj-52	144	7	a	a	PRON
ctmj-52	144	8	,	,	PUNCT
ctmj-52	144	9	senggunprai	senggunprai	NOUN
ctmj-52	144	10	l	l	NOUN
ctmj-52	144	11	,	,	PUNCT
ctmj-52	144	12	kukongviriyapan	kukongviriyapan	PROPN
ctmj-52	144	13	v.	v.	PROPN
ctmj-52	144	14	alendronate	alendronate	PROPN
ctmj-52	144	15	blocks	block	NOUN
ctmj-52	144	16	human	human	ADJ
ctmj-52	144	17	cholangiocarcinoma	cholangiocarcinoma	NOUN
ctmj-52	144	18	cell	cell	NOUN
ctmj-52	144	19	proliferation	proliferation	NOUN
ctmj-52	144	20	and	and	CCONJ
ctmj-52	144	21	migration	migration	NOUN
ctmj-52	144	22	.	.	PUNCT
ctmj-52	145	1	trop	trop	X
ctmj-52	145	2	j	j	PROPN
ctmj-52	145	3	pharm	pharm	PROPN
ctmj-52	145	4	res	re	VERB
ctmj-52	145	5	2019	2019	NUM
ctmj-52	145	6	;	;	PUNCT
ctmj-52	145	7	18(6	18(6	NUM
ctmj-52	145	8	):	):	PUNCT
ctmj-52	145	9	11791184	11791184	NUM
ctmj-52	145	10	.	.	PUNCT
ctmj-52	146	1	6	6	NUM
ctmj-52	146	2	.	.	X
ctmj-52	146	3	yu	yu	PROPN
ctmj-52	146	4	zw	zw	PROPN
ctmj-52	146	5	,	,	PUNCT
ctmj-52	146	6	zhang	zhang	PROPN
ctmj-52	146	7	j	j	PROPN
ctmj-52	146	8	,	,	PUNCT
ctmj-52	146	9	li	li	PROPN
ctmj-52	146	10	x	x	PROPN
ctmj-52	146	11	,	,	PUNCT
ctmj-52	146	12	wang	wang	PROPN
ctmj-52	146	13	y	y	PROPN
ctmj-52	146	14	,	,	PUNCT
ctmj-52	146	15	fu	fu	PROPN
ctmj-52	146	16	yh	yh	PROPN
ctmj-52	146	17	,	,	PUNCT
ctmj-52	146	18	gao	gao	PROPN
ctmj-52	146	19	xy	xy	PROPN
ctmj-52	146	20	.	.	PUNCT
ctmj-52	147	1	a	a	DET
ctmj-52	147	2	new	new	ADJ
ctmj-52	147	3	research	research	NOUN
ctmj-52	147	4	hot	hot	ADJ
ctmj-52	147	5	spot	spot	NOUN
ctmj-52	147	6	:	:	PUNCT
ctmj-52	147	7	the	the	DET
ctmj-52	147	8	role	role	NOUN
ctmj-52	147	9	of	of	ADP
ctmj-52	147	10	nlrp3	nlrp3	NOUN
ctmj-52	147	11	inflammasome	inflammasome	NOUN
ctmj-52	147	12	activation	activation	NOUN
ctmj-52	147	13	,	,	PUNCT
ctmj-52	147	14	a	a	DET
ctmj-52	147	15	key	key	ADJ
ctmj-52	147	16	step	step	NOUN
ctmj-52	147	17	in	in	ADP
ctmj-52	147	18	pyroptosis	pyroptosis	NOUN
ctmj-52	147	19	,	,	PUNCT
ctmj-52	147	20	in	in	ADP
ctmj-52	147	21	diabetes	diabetes	NOUN
ctmj-52	147	22	and	and	CCONJ
ctmj-52	147	23	diabetic	diabetic	ADJ
ctmj-52	147	24	complications	complication	NOUN
ctmj-52	147	25	.	.	PUNCT
ctmj-52	148	1	life	life	NOUN
ctmj-52	148	2	sci	sci	PROPN
ctmj-52	148	3	2020	2020	NUM
ctmj-52	148	4	;	;	PUNCT
ctmj-52	148	5	240	240	NUM
ctmj-52	148	6	:	:	SYM
ctmj-52	148	7	117138	117138	NUM
ctmj-52	148	8	.	.	PUNCT
ctmj-52	149	1	7	7	X
ctmj-52	149	2	.	.	X
ctmj-52	149	3	wei	wei	PROPN
ctmj-52	149	4	b	b	PROPN
ctmj-52	149	5	,	,	PUNCT
ctmj-52	149	6	gong	gong	PROPN
ctmj-52	149	7	y	y	PROPN
ctmj-52	149	8	,	,	PUNCT
ctmj-52	149	9	yang	yang	PROPN
ctmj-52	149	10	h	h	PROPN
ctmj-52	149	11	,	,	PUNCT
ctmj-52	149	12	zhou	zhou	PROPN
ctmj-52	149	13	j	j	PROPN
ctmj-52	149	14	,	,	PUNCT
ctmj-52	149	15	su	su	PROPN
ctmj-52	149	16	z	z	PROPN
ctmj-52	149	17	,	,	PUNCT
ctmj-52	149	18	liang	liang	PROPN
ctmj-52	149	19	z.	z.	PROPN
ctmj-52	149	20	role	role	NOUN
ctmj-52	149	21	of	of	ADP
ctmj-52	149	22	tumor	tumor	NOUN
ctmj-52	149	23	necrosis	necrosis	NOUN
ctmj-52	149	24	factor	factor	NOUN
ctmj-52	149	25	receptor‐associated	receptor‐associate	VERB
ctmj-52	149	26	factor	factor	NOUN
ctmj-52	149	27	6	6	NUM
ctmj-52	149	28	in	in	ADP
ctmj-52	149	29	pyroptosis	pyroptosis	NOUN
ctmj-52	149	30	during	during	ADP
ctmj-52	149	31	acute	acute	PROPN
ctmj-52	149	32	pancreatitis	pancreatitis	PROPN
ctmj-52	149	33	.	.	PUNCT
ctmj-52	150	1	mol	mol	ADP
ctmj-52	150	2	med	med	PROPN
ctmj-52	150	3	rep	rep	PROPN
ctmj-52	150	4	2021	2021	NUM
ctmj-52	150	5	;	;	PUNCT
ctmj-52	150	6	24(6	24(6	NUM
ctmj-52	150	7	):	):	PUNCT
ctmj-52	150	8	848	848	NUM
ctmj-52	150	9	.	.	NOUN
ctmj-52	150	10	8	8	NUM
ctmj-52	150	11	.	.	X
ctmj-52	150	12	nakamura	nakamura	PROPN
ctmj-52	150	13	n.	n.	PROPN
ctmj-52	150	14	the	the	DET
ctmj-52	150	15	role	role	NOUN
ctmj-52	150	16	of	of	ADP
ctmj-52	150	17	the	the	DET
ctmj-52	150	18	transmembrane	transmembrane	NOUN
ctmj-52	150	19	ring	ring	NOUN
ctmj-52	150	20	finger	finger	NOUN
ctmj-52	150	21	proteins	protein	NOUN
ctmj-52	150	22	in	in	ADP
ctmj-52	150	23	cellular	cellular	ADJ
ctmj-52	150	24	and	and	CCONJ
ctmj-52	150	25	organelle	organelle	NOUN
ctmj-52	150	26	function	function	NOUN
ctmj-52	150	27	.	.	PUNCT
ctmj-52	151	1	membranes	membrane	NOUN
ctmj-52	151	2	(	(	PUNCT
ctmj-52	151	3	basel	basel	PROPN
ctmj-52	151	4	)	)	PUNCT
ctmj-52	151	5	2011	2011	NUM
ctmj-52	151	6	;	;	PUNCT
ctmj-52	151	7	1(4	1(4	NUM
ctmj-52	151	8	):	):	PUNCT
ctmj-52	151	9	354	354	NUM
ctmj-52	151	10	-	-	SYM
ctmj-52	151	11	393	393	NUM
ctmj-52	151	12	.	.	PUNCT
ctmj-52	152	1	9	9	NUM
ctmj-52	152	2	.	.	X
ctmj-52	152	3	hör	hör	PROPN
ctmj-52	152	4	s	s	PROPN
ctmj-52	152	5	,	,	PUNCT
ctmj-52	152	6	ziv	ziv	PROPN
ctmj-52	152	7	t	t	PROPN
ctmj-52	152	8	,	,	PUNCT
ctmj-52	152	9	admon	admon	PROPN
ctmj-52	152	10	a	a	PRON
ctmj-52	152	11	,	,	PUNCT
ctmj-52	152	12	lehner	lehner	PROPN
ctmj-52	152	13	pj	pj	PROPN
ctmj-52	152	14	.	.	PROPN
ctmj-52	152	15	stable	stable	ADJ
ctmj-52	152	16	isotope	isotope	NOUN
ctmj-52	152	17	labeling	labeling	NOUN
ctmj-52	152	18	by	by	ADP
ctmj-52	152	19	amino	amino	ADJ
ctmj-52	152	20	acids	acid	NOUN
ctmj-52	152	21	in	in	ADP
ctmj-52	152	22	cell	cell	NOUN
ctmj-52	152	23	culture	culture	NOUN
ctmj-52	152	24	and	and	CCONJ
ctmj-52	152	25	differential	differential	ADJ
ctmj-52	152	26	plasma	plasma	NOUN
ctmj-52	152	27	membrane	membrane	NOUN
ctmj-52	152	28	proteome	proteome	NOUN
ctmj-52	152	29	quantitation	quantitation	NOUN
ctmj-52	152	30	identify	identify	VERB
ctmj-52	152	31	new	new	ADJ
ctmj-52	152	32	substrates	substrate	NOUN
ctmj-52	152	33	for	for	ADP
ctmj-52	152	34	the	the	DET
ctmj-52	152	35	march9	march9	NOUN
ctmj-52	152	36	transmembrane	transmembrane	NOUN
ctmj-52	152	37	e3	e3	NOUN
ctmj-52	152	38	ligase	ligase	NOUN
ctmj-52	152	39	.	.	PUNCT
ctmj-52	153	1	mol	mol	ADP
ctmj-52	153	2	cell	cell	NOUN
ctmj-52	153	3	proteomics	proteomic	NOUN
ctmj-52	153	4	2009	2009	NUM
ctmj-52	153	5	;	;	PUNCT
ctmj-52	153	6	8(8	8(8	NUM
ctmj-52	153	7	):	):	PUNCT
ctmj-52	153	8	1959	1959	NUM
ctmj-52	153	9	-	-	SYM
ctmj-52	153	10	1971	1971	NUM
ctmj-52	153	11	.	.	PUNCT
ctmj-52	154	1	10	10	NUM
ctmj-52	154	2	.	.	PUNCT
ctmj-52	155	1	lin	lin	PROPN
ctmj-52	155	2	m	m	PROPN
ctmj-52	155	3	,	,	PUNCT
ctmj-52	155	4	jin	jin	PROPN
ctmj-52	155	5	y	y	PROPN
ctmj-52	155	6	,	,	PUNCT
ctmj-52	155	7	wang	wang	PROPN
ctmj-52	155	8	f	f	PROPN
ctmj-52	155	9	,	,	PUNCT
ctmj-52	155	10	meng	meng	PROPN
ctmj-52	155	11	y	y	PROPN
ctmj-52	155	12	,	,	PUNCT
ctmj-52	155	13	huang	huang	PROPN
ctmj-52	155	14	j	j	PROPN
ctmj-52	155	15	,	,	PUNCT
ctmj-52	155	16	qin	qin	PROPN
ctmj-52	155	17	x	x	PROPN
ctmj-52	155	18	,	,	PUNCT
ctmj-52	155	19	fan	fan	PROPN
ctmj-52	155	20	z.	z.	PROPN
ctmj-52	155	21	march9	march9	PROPN
ctmj-52	155	22	mediates	mediate	VERB
ctmj-52	155	23	nox2	nox2	ADJ
ctmj-52	155	24	ubiquitination	ubiquitination	NOUN
ctmj-52	155	25	to	to	PART
ctmj-52	155	26	alleviate	alleviate	VERB
ctmj-52	155	27	nlrp3	nlrp3	ADJ
ctmj-52	155	28	inflammasome	inflammasome	NOUN
ctmj-52	155	29	-	-	PUNCT
ctmj-52	155	30	dependent	dependent	ADJ
ctmj-52	155	31	pancreatic	pancreatic	ADJ
ctmj-52	155	32	cell	cell	NOUN
ctmj-52	155	33	pyroptosis	pyroptosis	NOUN
ctmj-52	155	34	in	in	ADP
ctmj-52	155	35	acute	acute	PROPN
ctmj-52	155	36	pancreatitis	pancreatitis	PROPN
ctmj-52	155	37	.	.	PUNCT
ctmj-52	156	1	pancreas	pancrea	NOUN
ctmj-52	156	2	2023	2023	NUM
ctmj-52	156	3	;	;	PUNCT
ctmj-52	156	4	52(1	52(1	NUM
ctmj-52	156	5	):	):	PUNCT
ctmj-52	156	6	e62	e62	NOUN
ctmj-52	156	7	-	-	PUNCT
ctmj-52	156	8	e69	e69	NUM
ctmj-52	156	9	.	.	PUNCT
ctmj-52	157	1	11	11	NUM
ctmj-52	157	2	.	.	X
ctmj-52	158	1	world	world	PROPN
ctmj-52	158	2	medical	medical	PROPN
ctmj-52	158	3	association	association	PROPN
ctmj-52	158	4	declaration	declaration	PROPN
ctmj-52	158	5	of	of	ADP
ctmj-52	158	6	helsinki	helsinki	PROPN
ctmj-52	158	7	:	:	PUNCT
ctmj-52	158	8	ethical	ethical	ADJ
ctmj-52	158	9	principles	principle	NOUN
ctmj-52	158	10	for	for	ADP
ctmj-52	158	11	medical	medical	ADJ
ctmj-52	158	12	research	research	NOUN
ctmj-52	158	13	involving	involve	VERB
ctmj-52	158	14	human	human	ADJ
ctmj-52	158	15	subjects	subject	NOUN
ctmj-52	158	16	.	.	PUNCT
ctmj-52	159	1	jama	jama	PROPN
ctmj-52	159	2	2013	2013	NUM
ctmj-52	159	3	;	;	PUNCT
ctmj-52	159	4	310(20	310(20	NUM
ctmj-52	159	5	):	):	PUNCT
ctmj-52	159	6	2191	2191	NUM
ctmj-52	159	7	-	-	SYM
ctmj-52	159	8	2194	2194	NUM
ctmj-52	159	9	.	.	PUNCT
ctmj-52	160	1	chinese	chinese	ADJ
ctmj-52	160	2	traditional	traditional	ADJ
ctmj-52	160	3	medicine	medicine	NOUN
ctmj-52	160	4	journal	journal	NOUN
ctmj-52	160	5	|	|	ADV
ctmj-52	160	6	2020	2020	NUM
ctmj-52	161	1	|	|	ADV
ctmj-52	161	2	vol	vol	NOUN
ctmj-52	161	3	3	3	NUM
ctmj-52	161	4	|	|	ADV
ctmj-52	161	5	issue	issue	VERB
ctmj-52	161	6	5	5	NUM
ctmj-52	161	7	issn	issn	X
ctmj-52	161	8	:	:	PUNCT
ctmj-52	161	9	2693	2693	NUM
ctmj-52	161	10	6356	6356	NUM
ctmj-52	161	11	2020	2020	NUM
ctmj-52	161	12	|	|	ADV
ctmj-52	161	13	vol	vol	NOUN
ctmj-52	161	14	3	3	NUM
ctmj-52	161	15	|	|	ADV
ctmj-52	161	16	issue	issue	VERB
ctmj-52	161	17	5	5	NUM
ctmj-52	161	18	ctmj	ctmj	NOUN
ctmj-52	161	19	|	|	ADV
ctmj-52	161	20	traditionalmedicinejournals.com	traditionalmedicinejournals.com	X
ctmj-52	161	21	12	12	NUM
ctmj-52	161	22	.	.	PUNCT
ctmj-52	162	1	wang	wang	PROPN
ctmj-52	162	2	x	x	PROPN
ctmj-52	162	3	,	,	PUNCT
ctmj-52	162	4	qian	qian	PROPN
ctmj-52	162	5	j	j	PROPN
ctmj-52	162	6	,	,	PUNCT
ctmj-52	162	7	meng	meng	PROPN
ctmj-52	162	8	y	y	PROPN
ctmj-52	162	9	,	,	PUNCT
ctmj-52	162	10	wang	wang	PROPN
ctmj-52	162	11	p	p	PROPN
ctmj-52	162	12	,	,	PUNCT
ctmj-52	162	13	cheng	cheng	PROPN
ctmj-52	162	14	r	r	PROPN
ctmj-52	162	15	,	,	PUNCT
ctmj-52	162	16	zhou	zhou	PROPN
ctmj-52	162	17	g	g	PROPN
ctmj-52	162	18	,	,	PUNCT
ctmj-52	162	19	zhu	zhu	PROPN
ctmj-52	162	20	s	s	PART
ctmj-52	162	21	,	,	PUNCT
ctmj-52	162	22	liu	liu	PROPN
ctmj-52	162	23	c.	c.	PROPN
ctmj-52	162	24	salidroside	salidroside	NOUN
ctmj-52	162	25	ameliorates	ameliorate	VERB
ctmj-52	162	26	severe	severe	ADJ
ctmj-52	162	27	acute	acute	NOUN
ctmj-52	162	28	pancreatitis	pancreatitis	NOUN
ctmj-52	162	29	-	-	PUNCT
ctmj-52	162	30	induced	induce	VERB
ctmj-52	162	31	cell	cell	NOUN
ctmj-52	162	32	injury	injury	NOUN
ctmj-52	162	33	and	and	CCONJ
ctmj-52	162	34	pyroptosis	pyroptosis	NOUN
ctmj-52	162	35	by	by	ADP
ctmj-52	162	36	inactivating	inactivate	VERB
ctmj-52	162	37	akt	akt	PROPN
ctmj-52	162	38	/	/	SYM
ctmj-52	162	39	nf	nf	PROPN
ctmj-52	162	40	-	-	PUNCT
ctmj-52	162	41	κb	κb	NOUN
ctmj-52	162	42	and	and	CCONJ
ctmj-52	162	43	caspase3	caspase3	NOUN
ctmj-52	162	44	/	/	SYM
ctmj-52	162	45	gsdme	gsdme	NOUN
ctmj-52	162	46	pathways	pathway	NOUN
ctmj-52	162	47	.	.	PUNCT
ctmj-52	163	1	heliyon	heliyon	NOUN
ctmj-52	163	2	2023	2023	NUM
ctmj-52	163	3	;	;	PUNCT
ctmj-52	163	4	9(2	9(2	NUM
ctmj-52	163	5	):	):	PUNCT
ctmj-52	163	6	e13225	e13225	PROPN
ctmj-52	163	7	.	.	PROPN
ctmj-52	164	1	13	13	NUM
ctmj-52	164	2	.	.	PUNCT
ctmj-52	164	3	shen	shen	PROPN
ctmj-52	164	4	qm	qm	PROPN
ctmj-52	164	5	,	,	PUNCT
ctmj-52	164	6	wang	wang	PROPN
ctmj-52	164	7	hy	hy	PROPN
ctmj-52	164	8	,	,	PUNCT
ctmj-52	164	9	xu	xu	PROPN
ctmj-52	164	10	s.	s.	PROPN
ctmj-52	164	11	march9	march9	PROPN
ctmj-52	164	12	suppresses	suppress	VERB
ctmj-52	164	13	lung	lung	NOUN
ctmj-52	164	14	adenocarcinoma	adenocarcinoma	NOUN
ctmj-52	164	15	progression	progression	NOUN
ctmj-52	164	16	by	by	ADP
ctmj-52	164	17	downregulating	downregulate	VERB
ctmj-52	164	18	icam-1	icam-1	PROPN
ctmj-52	164	19	.	.	PUNCT
ctmj-52	165	1	cell	cell	PROPN
ctmj-52	165	2	physiol	physiol	PROPN
ctmj-52	165	3	biochem	biochem	PROPN
ctmj-52	165	4	2018	2018	NUM
ctmj-52	165	5	;	;	PUNCT
ctmj-52	165	6	50(1	50(1	NUM
ctmj-52	165	7	):	):	PUNCT
ctmj-52	165	8	92	92	NUM
ctmj-52	165	9	-	-	SYM
ctmj-52	165	10	107	107	NUM
ctmj-52	165	11	.	.	PUNCT
ctmj-52	166	1	14	14	NUM
ctmj-52	166	2	.	.	X
ctmj-52	166	3	de	de	PROPN
ctmj-52	166	4	angelis	angelis	PROPN
ctmj-52	166	5	rigotti	rigotti	VERB
ctmj-52	166	6	f	f	PROPN
ctmj-52	166	7	,	,	PUNCT
ctmj-52	166	8	de	de	PROPN
ctmj-52	166	9	gassart	gassart	PROPN
ctmj-52	166	10	a	a	PROPN
ctmj-52	166	11	,	,	PUNCT
ctmj-52	166	12	pforr	pforr	NOUN
ctmj-52	166	13	c	c	NOUN
ctmj-52	166	14	,	,	PUNCT
ctmj-52	166	15	cano	cano	PROPN
ctmj-52	166	16	f	f	PROPN
ctmj-52	166	17	,	,	PUNCT
ctmj-52	166	18	n'guessan	n'guessan	PROPN
ctmj-52	166	19	p	p	PROPN
ctmj-52	166	20	,	,	PUNCT
ctmj-52	166	21	combes	combes	PROPN
ctmj-52	166	22	a	a	PRON
ctmj-52	166	23	,	,	PUNCT
ctmj-52	166	24	camossetto	camossetto	NOUN
ctmj-52	166	25	v	v	ADP
ctmj-52	166	26	,	,	PUNCT
ctmj-52	166	27	lehner	lehner	PROPN
ctmj-52	166	28	pj	pj	PROPN
ctmj-52	166	29	,	,	PUNCT
ctmj-52	166	30	pierre	pierre	PROPN
ctmj-52	166	31	p	p	PROPN
ctmj-52	166	32	,	,	PUNCT
ctmj-52	166	33	gatti	gatti	PROPN
ctmj-52	166	34	e.	e.	PROPN
ctmj-52	166	35	march9	march9	PROPN
ctmj-52	166	36	-	-	PUNCT
ctmj-52	166	37	mediated	mediate	VERB
ctmj-52	166	38	ubiquitination	ubiquitination	NOUN
ctmj-52	166	39	regulates	regulate	VERB
ctmj-52	166	40	mhc	mhc	PROPN
ctmj-52	166	41	i	i	PRON
ctmj-52	166	42	export	export	VERB
ctmj-52	166	43	from	from	ADP
ctmj-52	166	44	the	the	DET
ctmj-52	166	45	tgn	tgn	NOUN
ctmj-52	166	46	.	.	PUNCT
ctmj-52	167	1	immunol	immunol	NOUN
ctmj-52	167	2	cell	cell	NOUN
ctmj-52	167	3	biol	biol	PROPN
ctmj-52	167	4	2017	2017	NUM
ctmj-52	167	5	;	;	PUNCT
ctmj-52	167	6	95(9	95(9	NUM
ctmj-52	167	7	):	):	PUNCT
ctmj-52	167	8	753	753	NUM
ctmj-52	167	9	-	-	SYM
ctmj-52	167	10	764	764	NUM
ctmj-52	167	11	.	.	PUNCT
ctmj-52	167	12	15	15	NUM
ctmj-52	167	13	.	.	PUNCT
ctmj-52	168	1	blevins	blevins	PROPN
ctmj-52	168	2	hm	hm	PROPN
ctmj-52	168	3	,	,	PUNCT
ctmj-52	168	4	xu	xu	PROPN
ctmj-52	168	5	y	y	PROPN
ctmj-52	168	6	,	,	PUNCT
ctmj-52	168	7	biby	biby	PROPN
ctmj-52	168	8	s	s	PROPN
ctmj-52	168	9	,	,	PUNCT
ctmj-52	168	10	zhang	zhang	PROPN
ctmj-52	168	11	s.	s.	PROPN
ctmj-52	168	12	the	the	DET
ctmj-52	168	13	nlrp3	nlrp3	PROPN
ctmj-52	168	14	inflammasome	inflammasome	NOUN
ctmj-52	168	15	pathway	pathway	NOUN
ctmj-52	168	16	:	:	PUNCT
ctmj-52	168	17	a	a	DET
ctmj-52	168	18	review	review	NOUN
ctmj-52	168	19	of	of	ADP
ctmj-52	168	20	mechanisms	mechanism	NOUN
ctmj-52	168	21	and	and	CCONJ
ctmj-52	168	22	inhibitors	inhibitor	NOUN
ctmj-52	168	23	for	for	ADP
ctmj-52	168	24	the	the	DET
ctmj-52	168	25	treatment	treatment	NOUN
ctmj-52	168	26	of	of	ADP
ctmj-52	168	27	inflammatory	inflammatory	ADJ
ctmj-52	168	28	diseases	disease	NOUN
ctmj-52	168	29	.	.	PUNCT
ctmj-52	169	1	front	front	ADJ
ctmj-52	169	2	aging	age	VERB
ctmj-52	169	3	neurosci	neurosci	NOUN
ctmj-52	169	4	2022	2022	NUM
ctmj-52	169	5	;	;	PUNCT
ctmj-52	169	6	14	14	NUM
ctmj-52	169	7	:	:	SYM
ctmj-52	169	8	879021	879021	NUM
ctmj-52	169	9	.	.	PUNCT
ctmj-52	170	1	16	16	NUM
ctmj-52	170	2	.	.	PUNCT
ctmj-52	171	1	mangan	mangan	PROPN
ctmj-52	171	2	msj	msj	PROPN
ctmj-52	171	3	,	,	PUNCT
ctmj-52	171	4	olhava	olhava	PROPN
ctmj-52	171	5	ej	ej	PROPN
ctmj-52	171	6	,	,	PUNCT
ctmj-52	171	7	roush	roush	PROPN
ctmj-52	171	8	wr	wr	PROPN
ctmj-52	171	9	,	,	PUNCT
ctmj-52	171	10	seidel	seidel	PROPN
ctmj-52	171	11	hm	hm	PROPN
ctmj-52	171	12	,	,	PUNCT
ctmj-52	171	13	glick	glick	PROPN
ctmj-52	171	14	gd	gd	PROPN
ctmj-52	171	15	,	,	PUNCT
ctmj-52	171	16	latz	latz	PROPN
ctmj-52	171	17	e.	e.	PROPN
ctmj-52	171	18	targeting	target	VERB
ctmj-52	171	19	the	the	DET
ctmj-52	171	20	nlrp3	nlrp3	ADJ
ctmj-52	171	21	inflammasome	inflammasome	NOUN
ctmj-52	171	22	in	in	ADP
ctmj-52	171	23	inflammatory	inflammatory	ADJ
ctmj-52	171	24	diseases	disease	NOUN
ctmj-52	171	25	.	.	PUNCT
ctmj-52	172	1	nat	nat	PROPN
ctmj-52	172	2	rev	rev	VERB
ctmj-52	172	3	drug	drug	PROPN
ctmj-52	172	4	discov	discov	PROPN
ctmj-52	172	5	2018	2018	NUM
ctmj-52	172	6	;	;	PUNCT
ctmj-52	172	7	17(8	17(8	NUM
ctmj-52	172	8	):	):	PUNCT
ctmj-52	172	9	588	588	NUM
ctmj-52	172	10	-	-	SYM
ctmj-52	172	11	606	606	NUM
ctmj-52	172	12	.	.	PUNCT
ctmj-52	173	1	17	17	NUM
ctmj-52	173	2	.	.	PUNCT
ctmj-52	174	1	li	li	PROPN
ctmj-52	174	2	y	y	PROPN
ctmj-52	174	3	,	,	PUNCT
ctmj-52	174	4	song	song	PROPN
ctmj-52	174	5	w	w	PROPN
ctmj-52	174	6	,	,	PUNCT
ctmj-52	174	7	tong	tong	PROPN
ctmj-52	174	8	y	y	PROPN
ctmj-52	174	9	,	,	PUNCT
ctmj-52	174	10	zhang	zhang	PROPN
ctmj-52	174	11	x	x	PROPN
ctmj-52	174	12	,	,	PUNCT
ctmj-52	174	13	zhao	zhao	PROPN
ctmj-52	174	14	j	j	PROPN
ctmj-52	174	15	,	,	PUNCT
ctmj-52	174	16	gao	gao	PROPN
ctmj-52	174	17	x	x	PROPN
ctmj-52	174	18	,	,	PUNCT
ctmj-52	174	19	yong	yong	PROPN
ctmj-52	174	20	j	j	PROPN
ctmj-52	174	21	,	,	PUNCT
ctmj-52	174	22	wang	wang	PROPN
ctmj-52	174	23	h.	h.	PROPN
ctmj-52	174	24	isoliquiritin	isoliquiritin	PROPN
ctmj-52	174	25	ameliorates	ameliorate	VERB
ctmj-52	174	26	depression	depression	NOUN
ctmj-52	174	27	by	by	ADP
ctmj-52	174	28	suppressing	suppress	VERB
ctmj-52	174	29	nlrp3	nlrp3	NOUN
ctmj-52	174	30	-	-	PUNCT
ctmj-52	174	31	mediated	mediate	VERB
ctmj-52	174	32	pyroptosis	pyroptosis	NOUN
ctmj-52	174	33	via	via	ADP
ctmj-52	174	34	mirna-27a	mirna-27a	PROPN
ctmj-52	174	35	/	/	SYM
ctmj-52	174	36	syk	syk	NOUN
ctmj-52	174	37	/	/	SYM
ctmj-52	174	38	nf	nf	ADJ
ctmj-52	174	39	-	-	PUNCT
ctmj-52	174	40	κb	κb	NOUN
ctmj-52	174	41	axis	axis	NOUN
ctmj-52	174	42	.	.	PUNCT
ctmj-52	175	1	j	j	PROPN
ctmj-52	175	2	neuroinflammation	neuroinflammation	PROPN
ctmj-52	175	3	2021	2021	NUM
ctmj-52	175	4	;	;	PUNCT
ctmj-52	175	5	18(1	18(1	NUM
ctmj-52	175	6	):	):	PUNCT
ctmj-52	175	7	1	1	NUM
ctmj-52	175	8	18	18	NUM
ctmj-52	175	9	.	.	PUNCT
ctmj-52	176	1	yan	yan	PROPN
ctmj-52	176	2	h	h	PROPN
ctmj-52	176	3	,	,	PUNCT
ctmj-52	176	4	luo	luo	PROPN
ctmj-52	176	5	b	b	PROPN
ctmj-52	176	6	,	,	PUNCT
ctmj-52	176	7	wu	wu	PROPN
ctmj-52	176	8	x	x	PROPN
ctmj-52	176	9	,	,	PUNCT
ctmj-52	176	10	guan	guan	PROPN
ctmj-52	176	11	f	f	PROPN
ctmj-52	176	12	,	,	PUNCT
ctmj-52	176	13	yu	yu	PROPN
ctmj-52	176	14	x	x	PROPN
ctmj-52	176	15	,	,	PUNCT
ctmj-52	176	16	zhao	zhao	PROPN
ctmj-52	176	17	l	l	PROPN
ctmj-52	176	18	,	,	PUNCT
ctmj-52	176	19	ke	ke	PROPN
ctmj-52	176	20	x	x	PROPN
ctmj-52	176	21	,	,	PUNCT
ctmj-52	176	22	wu	wu	PROPN
ctmj-52	176	23	j	j	PROPN
ctmj-52	176	24	,	,	PUNCT
ctmj-52	176	25	yuan	yuan	PROPN
ctmj-52	176	26	j.	j.	PROPN
ctmj-52	176	27	cisplatin	cisplatin	PROPN
ctmj-52	176	28	induces	induce	VERB
ctmj-52	176	29	pyroptosis	pyroptosis	NOUN
ctmj-52	176	30	via	via	ADP
ctmj-52	176	31	activation	activation	NOUN
ctmj-52	176	32	of	of	ADP
ctmj-52	176	33	meg3	meg3	PROPN
ctmj-52	176	34	/	/	SYM
ctmj-52	176	35	nlrp3	nlrp3	NOUN
ctmj-52	176	36	/	/	SYM
ctmj-52	176	37	caspase-1	caspase-1	NOUN
ctmj-52	176	38	/	/	SYM
ctmj-52	176	39	gsdmd	gsdmd	ADJ
ctmj-52	176	40	pathway	pathway	NOUN
ctmj-52	176	41	in	in	ADP
ctmj-52	176	42	triple	triple	ADJ
ctmj-52	176	43	-	-	PUNCT
ctmj-52	176	44	negative	negative	ADJ
ctmj-52	176	45	breast	breast	NOUN
ctmj-52	176	46	cancer	cancer	NOUN
ctmj-52	176	47	.	.	PUNCT
ctmj-52	177	1	int	int	NOUN
ctmj-52	177	2	j	j	PROPN
ctmj-52	177	3	biol	biol	PROPN
ctmj-52	177	4	sci	sci	PROPN
ctmj-52	177	5	2021	2021	NUM
ctmj-52	177	6	;	;	PUNCT
ctmj-52	177	7	17(10	17(10	NUM
ctmj-52	177	8	):	):	PUNCT
ctmj-52	177	9	2606	2606	NUM
ctmj-52	177	10	-	-	SYM
ctmj-52	177	11	2621	2621	NUM
ctmj-52	177	12	.	.	PUNCT